Cognitive and Behavioral Context of Pain Facilitation : Nocebo Conditioning and Uncontrollability-Induced Sensitization by Bräscher, Anne-Kathrin
  
COGNITIVE AND BEHAVIORAL CONTEXT OF PAIN 
FACILITATION - NOCEBO CONDITIONING AND 
UNCONTROLLABILITY-INDUCED SENSITIZATION 
 
 
INAUGURAL DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE 
DEGREE DOCTOR OF SOCIAL SCIENCES IN THE GRADUATE SCHOOL OF ECONOMIC AND SOCIAL 
SCIENCES AT THE UNIVERSITY OF MANNHEIM  
 
 
DIPL.-PSYCH. ANNE-KATHRIN BRÄSCHER    JUNE 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fakultät für Sozialwissenschaften der Universität Mannheim 
 
Dekan: Prof. Dr. Michael Diehl 
Referent: Prof. Dr. Rupert Hölzl 
Koreferentin: Prof. Dr. Herta Flor 
Koreferent: Jun.-Prof. Dr. Jörg Trojan 
Tag der Disputation: 28.04.2014 
 
 I 
Preface 
The studies presented in this thesis were conducted at the Otto Selz Institute for 
Applied Psychology at the University of Mannheim (Studies 1 and 2) and at the 
Alan Edwards Centre for Research on Pain (AECRP) at McGill University in 
Montreal, Canada (Study 3), during a research visit. Chapters 2.1 and 3 are 
intended for publication in modified form. Chapter 3 was developed in 
collaboration with Prof. Dr. Petra Schweinhardt. Prof. Dr. Kleinböhl developed a 
routine for the transformation of the raw heart rate data (Study 2) and contributed 
in the technical implementation of Study 3, amongst others.  
I received scholarships from the Center for Doctoral Studies in Social and 
Behavioral Sciences (CDSS) of the Graduate School of Economic and Social Sciences 
of the University of Mannheim, from the German National Academic Foundation 
(Studienstiftung des deutschen Volkes), and from the German Pain Society 
(Deutsche Schmerzgesellschaft). Studies 1 and 2 were further supported by funds 
from the Heinrich-Vetter foundation. 
Many people were involved in the success of this work, but some deserve special 
citation:  
I am indebted to Dr. Susanne Becker who supervised and supported me from near 
and far and was just a phenomenal advisor. I further want to thank Prof. Dr. 
Rupert Hölzl and Prof. Dr. Dieter Kleinböhl who provided the opportunity to realize 
my ideas and gave me manifold support and input at various stages of the process. 
I would like to particularly thank Prof. Dr. Petra Schweinhardt who enabled the 
instructive research visit in Montreal and who considerably supported the 
advancement of this thesis.  
I further want to thank Dr. Martin Riemer and my other colleagues at the Otto Selz 
Institute and the AECRP for the pleasant working atmosphere and their help in 
different ways, especially Dipl.-Ing. Otto Martin for technical support and Andrew 
White, M.Sc., for proofreading. Last, but not least, I want to thank my family and 
friends, who supported and motivated me during this project. Especially Dipl.-
Psych. Josepha Zimmer and my parents, Birgit and Lothar Bräscher, deserve to find 
special mention here. 
 

 III 
Table of Contents 
 
Preface ......................................................................................................................... I 
Abbreviations ............................................................................................................ V 
1. General Introduction .......................................................................................... 1 
1.1 Placebo and Nocebo Effects ............................................................................. 2 
1.2 Uncontrollability and Pain Perception ...........................................................10 
1.3 Methods of Pain Assessment .........................................................................14 
1.4 Aims of This Thesis .........................................................................................16 
2. Conditioned Nocebo Effects in Heat-Pain Perception .....................................19 
2.1 Classical Nocebo-Conditioning of Heat-Pain Perception: Dissociation of 
Subjective Rating and Implicit Behavioral Response ...........................................19 
2.2 Conditioned Nocebo-Hyperalgesia and Its Relation to Autonomic Indices and 
Personality Traits ..................................................................................................39 
3. Neural Correlates of Pain Sensitization Induced by Uncontrollability .............55 
4. General Discussion ...........................................................................................73 
4.1 Classical Conditioning of the Nocebo Effect .............................................73 
4.2 The Role of Awareness in Nocebo-Conditioning ......................................78 
4.3 Increased Sensitization Induced by Uncontrollability ..............................81 
4.4 Multidimensional Assessment of the Pain Response ...............................85 
4.5 Clinical Relevance .....................................................................................87 
4.6 Conclusions and Outlook ..........................................................................89 
Summary ..................................................................................................................91 
References ................................................................................................................93 
Appendix.................................................................................................................115 
 

 V 
Abbreviations 
ACC anterior cingulate cortex 
CCK cholecystokinin 
CR conditioned response  
CS conditioned stimulus 
DNICS  diffuse noxious inhibitory controls 
fMRI functional magnetic resonance imaging 
HSA hypothalamic-sympathetic-adrenal  
JND just noticeable difference 
LEPs laser-evoked potentials  
LMM linear mixed model 
PAG periaqueductal grey 
PASS Pain Anxiety Symptom Scale  
PCA patient-controlled analgesia  
PFC prefrontal cortex 
SI primary somatosensory cortex 
SII  secondary somatosensory cortex 
STAI State-Trait Anxiety Inventory 
rTMS repetitive transcranial magnetic stimulation 
UR unconditioned reaction 
US unconditioned stimulus 
VAS visual analog scale 
 
 
 
 
 
 
 
 

1. General Introduction 
1 
1. General Introduction 
According to the International Association for the Study of Pain (IASP), pain is “an 
unpleasant sensory and emotional experience, associated with actual or potential 
tissue damage or described in terms of such damage” (Merskey & Bogduk, 1994). 
It is a subjective sensory and emotional experience, susceptible to the influence of 
various pain-modulating factors (McGrath, 1994; Staats, Hekmat, & Staats, 1996; 
Tracey, 2008), like the environment (Abbott, Franklin, & Connell, 1986; 
Malenbaum, Keefe, Williams, Ulrich, & Somers, 2008), learning (Becker, Kleinböhl, 
Baus, & Hölzl, 2011; Flor, Birbaumer, Hermann, Ziegler, & Patrick, 2002), attention 
(Bantick et al., 2002; Valet et al., 2004), emotion (Roy, Piche, Chen, Peretz, & 
Rainville, 2009; Villemure, Slotnick, & Bushnell, 2003), cognition (Seminowicz & 
Davis, 2006; Weissman-Fogel, Sprecher, & Pud, 2008), and contextual factors 
(Moseley & Arntz, 2007). The pain experience usually depends on noxious 
stimulation, peripheral nociceptive activity, and central processing and can be 
modulated already at low levels of the nervous system (Wall, Melzack, & Bonica, 
1999), such as in peripheral sensitization (Woolf & Salter, 2000) as well as in later 
stages of the pain processing cascade (Lorenz, Minoshima, & Casey, 2003). 
Extreme examples that illustrate the complex interplay between the various 
components involved in pain processing are phantom pain and a rare condition 
called congenital insensitivity to pain (CIP). In phantom pain, a pain experience is 
evoked without direct (peripheral) nociceptive input of the apparently affected 
location, even without existence of the pain-causing limb. Although in many 
instances the stump receives nociceptive input, for example due to a stump 
neuroma, studies suggest that this subjective pain perception—despite missing 
counterpart in the body’s outer appearance—depends in part on reorganization 
processes in somatosensory cortical areas (Flor, Nikolajsen, & Staehelin Jensen, 
2006; Karl, Birbaumer, Lutzenberger, Cohen, & Flor, 2001). Interestingly, mirror 
therapy seems to reduce phantom pain in many cases, which can be attributed to 
somatosensory learning processes and corresponding cortical restructuring 
(MacLachlan, McDonald, & Waloch, 2004). In contrast, patients with CIP do not 
feel physical pain at all, probably due to a genetic abnormality that causes 
malfunctioning nociceptors (Nilsen et al., 2009). These patients often suffer from 
severe injuries, especially in their childhood, because their body’s warning system 
is amiss. They have to learn consciously and with great effort what comes naturally 
to unaffected people, for instance not to touch a hotplate, because they lack the 
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flexor reflex normally causing a defensive reaction. Both phantom pain and CIP 
illustrate that pain is a complex phenomenon, depending on the interplay between 
numerous components. In healthy subjects, it helps to protect the body against 
injury and harm by incorporating various external and internal factors of influence, 
thereby remaining flexible and plastic.   
As the success of interventions like mirror therapy demonstrates, the pain 
experience can be altered and influenced by psychological factors. Besides 
deliberate therapeutic strategies, pain modulation can, and indeed does, most of 
the time occur without the subject being aware of it. A wound, for example, will be 
less bothersome as soon as a patient is distracted. Factors of influence can either 
be inhibitory (e.g., placebo, distraction, stress-induced analgesia, sense of control) 
or facilitatory (e.g., attention, nocebo, catastrophizing thoughts). Compared to 
pain-inhibiting factors, pain facilitation is less studied, although it is possibly an 
important determinant in chronic pain (Turk & Okifuji, 2002). In this thesis, 
exemplarily for different psychological factors potentially involved in pain 
facilitation, the specific cases of conditioning-induced nocebo effect and 
uncontrollability are investigated. Both are supposed to be important factors in 
the context of chronic pain and have to be dealt with in clinical routine. Although 
different mechanisms are at work, evidence suggests that nocebos and 
uncontrollability can lead to increased fear (Bingel et al., 2011; Crombez, 
Eccleston, De Vlieger, Van Damme, & De Clercq, 2008) and feelings of helplessness 
(Müller, 2011; Vogtle, Barke, & Kroner-Herwig, 2013), contributing to a self-
maintaining vicious circle of pain that potentially activates the descending pain 
modulatory system.  
 
1.1 Placebo and Nocebo Effects 
The significance of the placebo effect (i.e., a desirable effect after an inert 
treatment) is widely recognized: One can take advantage of it in clinical situations 
(e.g., lowering the dosage of medication) and it plays a major role in the 
conduction of pharmaceutical studies, for example, when subjects in the placebo 
group show major improvements although the treatment is inert. The nocebo 
effect (i.e., an undesirable effect after an inert treatment), although less well-
understood, significantly affects clinical situations, as well: It can cause, for 
example, deterioration of symptoms in adverse physician-patient support or when 
a patient is diagnosed with a severe disease. Extreme examples are cases of 
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apparently life threatening events (“Beinahe-Tod”) as a consequence of voodoo 
magic, acting as a nocebo (Cannon, 2002). Research concerning the nocebo effect 
can shed light on the occurrence of side effects (Kaptchuk et al., 2006), processes 
in acute pain, and factors contributing to chronic pain, because the development 
and maintenance of chronic pain are affected by psychological factors, as outlined 
above.  
More precisely, a placebo (Latin: “I shall please”), according to Stewart-Williams & 
Podd (2004), is “a substance or procedure that has no inherent power to produce 
an effect that is sought or expected” (p. 326). The placebo effect is “a genuine 
psychological or physiological effect, in a human or another animal, which is 
attributable to receiving a substance or undergoing a procedure, but is not due to 
the inherent powers of that substance or procedure” (p. 326). This definition does 
not make assumptions about the desirability of the effects and therefore includes 
what is often labeled the ‘nocebo effect’, i.e., a ‘negative’ placebo (for example 
pain increase instead of pain relief). Incorporating both phenomena in a single 
expression avoids some pitfalls (e.g., some placebos might show desirable and 
undesirable effects at the same time or different subjects might interpret the same 
effect oppositional). Yet, explicitly distinguishing between placebo and nocebo 
(Latin: “I shall harm”) and respectively placebo and nocebo effects seems to be 
essential because evidence suggests that in part, different principles apply 
(Colloca, Sigaudo, & Benedetti, 2008). The expression ‘nocebo effect’ stresses 
aversive consequences and is defined by  Benedetti, Lanotte, Lopiano, & Colloca 
(2007) as “a phenomenon whereby anticipation and expectation of a negative 
outcome may induce the worsening of a symptom” (p. 260).  
Psychological mechanisms of placebo and nocebo effects 
Current research explains placebo and nocebo effects across different systems 
(nociceptive, immune, motor, etc.) mainly by means of two mechanisms: classical 
conditioning and expectancy (Stewart-Williams & Podd, 2004). It is commonly 
accepted that these mechanisms can cause placebo and nocebo effects both 
independently (i.e., only by expectation) and in combination, depending on the 
system or disease in question. Recent evidence further suggests that observational 
learning is capable to cause placebo (Colloca & Benedetti, 2009) and nocebo 
effects (Vogtle et al., 2013). Especially in the context of pain, the exact 
interrelations and conditions that cause placebo and nocebo effects are far from 
being clearly established, yet. For example the significance of conditioning remains 
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controversial for the nocebo effect and whether learning is effective if it occurs 
without awareness (like in implicit conditioning) is not known, yet. However, 
precise knowledge of the exact mechanisms of placebo and nocebo effects in pain 
perception is necessary, e.g., to control for the effects in pharmaceutical studies 
and to maximize the benefit in a therapeutic context. When the conditions under 
which the placebo and nocebo effect are shaped by conditioning and/or 
expectancy are understood clearly, the treatment can be adopted accordingly. If 
applicable, one can consider and integrate laws of conditioning, like generalization, 
blocking, latent inhibition, etcetera. For example, if latent inhibition applies, it is 
probable that an ineffective treatment can have negative consequences for a 
subsequent treatment attempt. In cases, in which expectation is considered very 
important, a consequence for the treatment could be to carefully consider the 
choice of words or to take extra time for explaining the expected positive effects.  
The nocebo effect and its mechanisms are less well explored compared to its more 
desirable counterpart (Kong et al., 2008). There is evidence that a nocebo effect is 
not just a reversed placebo effect, although probably the same basic mechanisms 
as for the placebo effect apply to the nocebo effect (Benedetti, Amanzio, Vighetti, 
& Asteggiano, 2006; Colloca et al., 2008; Kong et al., 2008). For instance, an 
additional learning procedure, compared to conscious expectation by verbal 
suggestions only, did not lead to further enhancement of the nocebo effect, but it 
led to an increased placebo effect (Colloca et al., 2008). Further, in the research of 
placebo and nocebo effects it should be noted that those effects are not uniform 
constructs, but differ depending on different systems and diseases (e.g., pain 
relief, improvement of motor functioning, allergic reactions, depression; 
Benedetti, Mayberg, Wager, Stohler, & Zubieta, 2005; Benedetti, 2008). Different 
placebo and nocebo effects are probably even caused by various mechanisms.  
According to expectancy theory, a placebo/nocebo effect occurs because a 
placebo/nocebo induces a specific expectation (Stewart-Williams & Podd, 2004). It 
is worth noting that expectancy, here, is understood as consciously accessible (in 
humans: reportable). In the experimental setting, expectations are mostly induced 
by verbal suggestions (e.g., the experimenter explains to the subject that a 
powerful analgesic is applied). However, the administration of a placebo/nocebo 
in form of an ointment or a tablet (without any additional verbal suggestion) can 
already induce expectations. Further, expectancy theory only refers to verbally 
reportable expectations and therefore does not take into account the occurrence 
of expectancies without awareness (e.g., measurable through anticipatory 
physiological parameters). Unconscious (or implicit) expectancies (“beliefs”, Haug, 
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2011), however, refer to content that is potentially consciously accessible, for 
example when attention is drawn to it (Haug, 2011).  
In classical conditioning, a formerly neutral stimulus, for example a bell, becomes a 
conditioned stimulus (CS), capable of triggering a specific response when it is 
repeatedly coupled to an unconditioned stimulus (US), e.g., food that evokes an 
unconditioned response (UR), like salivation. Subsequently, the presentation of the 
CS alone leads to a response (conditioned response, CR), that is similar to the UR 
(but can differ in latency, amplitude and configuration; Hilgard, 1936). In most 
cases, explicit classical conditioning takes place, meaning that during the 
procedure the subjects become aware of the contingencies between CS and US. 
When the subjects can report this relationship, an expectation has evolved as an 
epiphenomenon of the conditioning (Kirsch, 2004). However, classical conditioning 
can also occur implicitly, i.e., without the subject being aware of the contingencies 
between CS and US (Clark, Manns, & Squire, 2002; Manns, Clark, & Squire, 2001; 
Manns, Clark, & Squire, 2002, for review). In these instances, the development of a 
conscious expectation can be excluded.  
Conditioning emphasizes the importance of learning through direct experience 
(Voudouris, Peck, & Coleman, 1990). When, in the specific context of pain, the 
placebo effect is explained in terms of classical conditioning (Wickramasekera, 
1980), an active drug or procedure (e.g., an analgesic) serves as unconditioned 
stimulus leading to pain relief (UR). The active agent might be administered in 
form of a pill, so that the pill serves as CS. After repeated simultaneous 
presentation, the pill itself, lacking an active agent (and therefore representing a 
placebo), leads to pain relief (CR). This conditioned response represents the 
placebo effect. In cases in which the drug or procedure leads to aversive 
consequences, such as a burning sensation, a nocebo effect was induced. The role 
of conditioning in the placebo and nocebo context is supported by animal studies, 
as the concept of conscious expectation does not apply here. Examples for 
conditioning-induced nocebo effects in animal models are immunosuppression 
after illness-induced taste aversion in the rat (Ader & Cohen, 1975) and disruption 
of learned behavior by saline injection after conditioning with a suppressive drug 
(Herrnstein, 1962). Experiments demonstrated that typical characteristics of 
conditioning (e.g., stronger US produce stronger CR, i.e., dose-dependency, 
extinction) apply (Gliedman, Gantt, & Teitelbaum, 1957). 
Both expectancy and conditioning can induce physiological (objectively 
measurable) and subjective placebo and nocebo effects (Benedetti et al., 2006; 
1. General Introduction 
 
6 
Colloca & Benedetti, 2006; Colloca et al., 2008; Colloca et al., 2009). Evidence 
suggests that conditioning causes stronger (Voudouris et al., 1990) and longer 
lasting placebo effects than verbal suggestions (Klinger, Soost, Flor, & Worm, 
2007). In the context of pain, interestingly, placebo-hypoalgesia that was induced 
by conditioning can be mediated by various neurobiological mechanisms (Amanzio 
& Benedetti, 1999): When the subjects were conditioned with a non-opioidergic 
analgesic (e.g., ketorolac), the conditioned response was mediated by non-opioid 
mechanisms (naloxone-insensitive), whereas when the subjects were conditioned 
with an opioidergic analgesic, like morphine, the conditioned response relied on 
opioidergic mechanisms (naloxone-reversible). In contrast, expectancy-induced 
hypoalgesia seemed to depend solely on opioidergic mechanisms (naloxone-
reversible). Further studies found evidence for a positive relation between the 
individual placebo response and dopamine release (Scott et al., 2007). Here, 
positive expectations were interpreted as a special case of reward anticipation 
(Petrovic et al., 2005). These results support the notion that expectation- and 
conditioning-induced placebo effects are not dependent upon identical 
mechanisms. However, studies that exclusively employ a conditioning procedure 
to induce placebo or nocebo effects allowing to separate the effects of both 
mechanisms are scarce. 
According to Benedetti et al. (2003), only immune and hormonal placebo 
responses can be caused by conditioning. Placebo effects in other systems, like the 
nociceptive system, are supposed to be mediated necessarily by conscious 
expectations, which can be formed through conditioning or verbal suggestions 
(Price, Finniss, & Benedetti, 2008). Stewart-Williams & Podd (2004), on the other 
hand, come to the conclusion that placebo and nocebo effects can occur without 
expectancy only when classical conditioning is mediated through pharmacological 
agents that provoke physiological changes, which are not consciously perceived by 
the subjects. For example, Benedetti et al. (1998) and Benedetti, Amanzio, Baldi, 
Casadio, & Maggi (1999) induced placebo respiratory effects that resulted from 
buprenorphine conditioning and were not noticed by the subjects. Both Stewart-
Williams & Podd (2004) and Benedetti et al. (2003) concur in stating that 
conditioning only and exclusively is sought to cause a placebo effect (without 
expectancy) when this effect is unaware (Benedetti et al., 2003: immune or 
hormonal changes; Stewart-Williams & Podd, 2004: pharmacological effects). 
However, it is not clear why conditioning without the induction of conscious 
expectations should not be sufficient to induce placebo and nocebo effects in the 
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nociceptive system. Further, the role of contingency awareness has not been 
investigated in the context of placebo and nocebo conditioning.  
Assessment of placebo and nocebo effects 
In past research, placebo and nocebo effects have almost always been studied by 
means of subjective ratings (e.g., numeric pain ratings; Benedetti et al., 2003; 
Colloca & Benedetti, 2006; Colloca et al., 2008; Colloca & Benedetti, 2009; Colloca, 
Petrovic, Wager, Ingvar, & Benedetti, 2010). However, placebo and nocebo 
manipulations (e.g., verbal suggestions of pain increase) do not necessarily result 
in subjectively altered pain ratings (Johansen, Brox, & Flaten, 2003; Vogtle et al., 
2013). There are only few studies that implemented other assessment methods, 
like behavioral measures (e.g., pain tolerance in the tourniquet test, Amanzio & 
Benedetti, 1999; velocity of movement in patients with Parkinson’s disease, 
Benedetti et al., 2003). Goffaux, Redmond, Rainville, & Marchand (2007), for 
example, found increased withdrawal reflexes after hyperalgesia compared to 
hypoalgesia suggestions in a DNICS (diffuse noxious inhibitory controls) paradigm. 
Further, psychophysiological measures assessing autonomic changes are rather 
rarely studied and results are inconsistent, probably varying with the outcome 
variable and the experimental paradigm. For example, after placebo manipulation, 
de Jong, van Baast, Arntz, & Merckelbach (1996) did not find conditioned skin 
conductance responses despite pain decreases on a subjective level. In another 
study by Pollo, Vighetti, Rainero, & Benedetti (2003), placebo administration 
accompanied by a verbal instruction caused reduced heart rate and sympathetic 
responses. Contrary to that, Matre, Casey, & Knardahl (2006) demonstrated 
reduced heat pain sensitivity and smaller hyperalgesic and allodynic areas but no 
effect on heart rate and blood pressure after placebo manipulation with a sham 
magnet. Kirsch & Weixel (1988) showed expected effects on pulse rate and systolic 
blood pressure in a deception but not in a double-blind placebo administration. In 
another study, a dissociation between different measures was found: Following a 
conditioning procedure, but not a verbal suggestion, subjective pain ratings 
decreased. However, compared to a control group, laser-evoked potentials (LEPs) 
were strongly decreased in the conditioning group and to a weaker degree also 
decreased in the verbal suggestion group. This dissociation between subjective 
rating and LEP suggests that a certain threshold might have to be reached until the 
placebo effect is detectable in conscious perception or in the subjective rating 
(Colloca et al., 2009).  
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In summary, most studies assess placebo and nocebo effects with subjective 
ratings. Although evidence shows that subjective ratings cannot comprehensively 
capture and represent the changes induced by a placebo or nocebo, especially for 
the nocebo effects only few studies exist that investigate psychophysiological and 
behavioral measures.  
Nocebo effects in pain perception 
In the context of pain, a nocebo leads to increased pain sensitivity (nocebo-
hyperalgesia), which can be assessed, for instance, by means of decreased pain 
threshold or increased pain sensation. Although far less is known about the 
mechanisms of nocebo-hyperalgesia, literature suggests that probably the same 
basic mechanisms as for the placebo effect (i.e., expectancy, conditioning) apply to 
the nocebo effect (Colloca et al., 2008).  
Expectation-induced nocebo effects: It is assumed that verbally induced negative 
expectations (e.g., “This procedure will lead to increased pain sensitivity.”) induce 
anticipatory anxiety about the impeding pain. This anxiety (indicated by 
hypothalamic-sympathetic-adrenal (HSA) hyperactivity) is sought to activate 
cholecystokinin (CKK), a neuromodulator implicated in pain modulation and 
anxiety (Hebb, Poulin, Roach, Zacharko, & Drolet, 2005). Whereas both HSA 
hyperactivity and hyperalgesia were blocked with benzodiazepines, suggesting the 
involvement of anxiety in the formation of the hyperalgesia, the CCK-antagonist 
proglumide proved to antagonize only the nocebo-hyperalgesia, leaving anxiety-
related HSA hyperactivity unaffected. Thus anxiety-triggered CCK activation was 
assumed to facilitate the pain transmission, finally resulting in hyperalgesia 
(Benedetti & Amanzio, 1997; Benedetti, Amanzio, Casadio, Oliaro, & Maggi, 1997; 
Benedetti et al., 2006; Colloca & Benedetti, 2007, for review).  
Conditioning-induced nocebo effects: Based on results from animal studies, 
Voudouris, Peck, & Coleman (1985) introduced a conditioning design for humans 
in order to induce placebo and nocebo effects serving as model for many 
subsequent conditioning studies. They applied an inert cream along with a 
suggestion of pain relief and surreptitiously increased (nocebo manipulation) or 
decreased (placebo manipulation) stimulus intensities on trials with cream 
compared to trials without cream and observed changes in pain ratings in the 
direction according to the manipulation. In an analogous experiment, they further 
demonstrated that conditioned nocebo, but not placebo responses generalized 
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from an iontophoretic to an ischemic pain model (Voudouris, Peck, & Coleman, 
1989). 
Colloca et al. (2008) directly compared placebo-hypoalgesia and nocebo-
hyperalgesia either when only a verbal suggestion was given, or an additional 
conditioning procedure was conducted before the verbal suggestion. For the 
placebo effect, conditioning played a major role because verbal suggestions alone 
led to less pain decrease compared to the combination of conditioning and verbal 
suggestions (cf. Voudouris et al., 1990). For the nocebo effect, however, additional 
conditioning did not lead to further increases in the pain ratings compared to 
verbal suggestions alone. The authors concluded that learning is less important in 
nocebo-hyperalgesia compared to placebo-hypoalgesia (Colloca et al., 2008; 
Petrovic, 2008). However, this conclusion appears to be premature because the 
effect of conditioning was only investigated in combination with a verbal 
suggestion. In order to truly evaluate the impact of conditioning on nocebo effects, 
studies need to induce nocebo-hyperalgesia by conditioning alone. Only one study 
so far, induced a nocebo effect by conditioning alone, without giving additional 
verbal suggestions or other cues (e.g., pills) that potentially induce expectations 
from the outset (Jensen et al., 2012). The results demonstrated that nocebo-
hyperalgesia could be successfully induced after conditioning. A nocebo effect 
even occurred when the facial stimuli, serving as CS, were presented subliminally, 
indicating that nocebo effects can be activated by perceptions that stay beyond 
the level of consciousness. However, during conditioning, the CS were presented 
supraliminal and contingency awareness was not assessed. Thus, whether a 
nocebo effect can be induced by implicit conditioning as well remains to be 
determined. 
To summarize, according to previous research, the placebo effect in the context of 
pain can be established through expectation or conditioning. But when it is 
established by conditioning, it is sought to be mediated by expectation that 
developed during the conditioning procedure. The nocebo effect is mainly 
assumed to depend on expectation, although in a recent study, nocebo-
hyperalgesia could be activated by subliminally presented cues after an explicit 
conditioning procedure (Jensen et al., 2012).  
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1.2 Uncontrollability and Pain Perception 
An important factor influencing the reception of aversive events and especially the 
pain perception is somebody’s sense of control. Although Study 3 of this thesis is 
concerned with the effect of uncontrollability (i.e., lack of control) on painful 
stimulation, most research has focused on the impact of having control rather 
than not having it.  
Control can be defined as “some behavior (overt or covert) that reliably changes 
something else” (Arntz & Schmidt, 1989). Here, the subjective perception of 
control is most essential, which becomes obvious in Thompson's (1981) definition, 
who puts control as the “belief that one has at one’s disposal a response that can 
influence the aversiveness of an event” (p. 89). The notion that controllability 
affects the aversiveness of an event, or, specifically in the context of pain, the 
painfulness, seems self-evident and in concordance with our personal experience. 
Accordingly, especially chronic pain patients seek control for their conditions. 
However, reviews on this topic do not always entirely agree. Whereas Averill 
(1973) and Thompson (1981) come to the conclusion that controllability does not 
reliably decrease the impact of aversive events, Miller (1979), who investigated 
effects of behavioral control, concluded that controllable aversive events may 
have less negative effects. Finally, Arntz & Schmidt (1989) restricted their analysis 
to the control of noxious, painful stimuli and summarized that perceived control 
can reduce negative effects of pain, depending on the outcome measure 
(subjective, behavioral, physiological), type of control, and salience.  
In the context of control, many related concepts play a role, for example learned 
helplessness, and coping. Learned helplessness (Abramson, Seligman, & Teasdale, 
1978) “refers to a constellation of behavioral changes that follow exposure to 
stressors that are not controllable by means of behavioral responses, but that fail 
to occur if the stressor is controllable” (p. 829, Maier & Watkins, 2005). It can 
result in motivational, cognitive, and learning deficits (Seligman & Maier, 1967; 
Seligman, Rosellini, & Kozak, 1975, cited after Abramson et al. 1978) and serves as 
a model for clinical depression (Abramson, Metalsky, & Alloy, 1989). Coping is 
understood as “purposeful efforts to manage or vitiate the negative impact of 
stress” (p. 250, Jensen, Turner, Romano, & Karoly, 1991). In the context of pain, it 
is defined as efforts, usually involving cognitive and behavioral strategies, to cope 
with, deal with, and minimize pain and pain-related distress and disability 
(Rosenstiel & Keefe, 1983). A coping strategy can consist of relaxation, distraction, 
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positive self-statements, imagery strategies, hypnosis, stress inoculation training, 
cognitive transformation of the situation, etc. (Arntz & Schmidt, 1989). Coping self-
statements and reinterpretation of pain sensations predict greater perceived 
control, as well as flexibility in coping (Haythornthwaite, Menefee, Heinberg, & 
Clark, 1998). 
Typology and effects of control  
Control can be distinguished into different types, which potentially have 
differential effects on the painfulness of events. Averill (1973; also refer to 
Thompson, 1981) suggested a classification into behavioral control (the availability 
of a response that may directly influence or modify the objective characteristics of 
a threatening event; either regulated administration or stimulus modification), 
cognitive control (the processing of potentially threatening material in such a way 
as to reduce the net long-term stress or psychic costs of adaption, e.g., 
reappraisal), and decisional control (the opportunity to choose among various 
courses of action). Miller (1979) further dissected behavioral control into 
instrumental control (the ability to make a behavioral response that modifies the 
aversive event), self-administration (the self-delivery of the aversive event), actual 
control equated for predictability (controllability and predictability are kept 
methodologically distinct), and potential control (the person believes that some 
controlling response is available but is not actually used). Finally, Arntz & Schmidt 
(1989) expanded this list with the concept of loss of control and thereby for the 
first time explicitly focused on uncontrollability (cf. Staub, Tursky, & Schwartz, 
1971). In this thesis (Study 3), subjects are given instrumental control over the 
intensity of a temperature stimulus before their task changes and they lose control 
over the temperature input.  
Evidence shows that behavioral control most reliably affects the painfulness of an 
event (Arntz & Schmidt, 1989, for review). It increases pain tolerance (Bowers, 
1968; Litt, 1988), affects physiological measures (heart rate, Weisenberg, Wolf, 
Mittwoch, Mikulincer, & Aviram, 1985; skin conductance response, Corah & Boffa, 
1970), and decreases subjective pain report (Borckardt et al., 2011; Bowers, 1968; 
Weisenberg et al., 1985). Uncontrollable painful stimulation, on the other side, 
increases perceived pain intensity (Müller, 2012; Wiech et al., 2006) and cortisol 
secretion as an indicator of the stress response (Müller, 2011) and leads to 
decreased pain tolerance (Staub et al., 1971). Losing control, compared to never 
having had control at all, leads to a more unpleasant pain experience, increased 
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fear, heightened vigilance to the pain sensation, and impaired post-exposure 
performance (Crombez et al., 2008). Repeated failing attempts to control pain 
resulted in increased anger and heart rate responses (Janssen, Spinhoven, & Arntz, 
2004).  
Psychological and neural mechanisms of (un)controllability 
Different theories exist that try to establish how control influences the pain 
experience. Whereas Bowers (1968) hypothesized that anxiety mediates the level 
of pain in case of perceived lack of control (Wiech et al., 2006), Arntz & Schmidt 
(1989) put this theory into perspective, since anxiety seems to intensify the pain 
experience only if the focus of anxiety is on the pain. This rather speaks in favor for 
an effect of attention and identifies anxiety as an epiphenomenon of 
uncontrollability, which is not necessarily causally related to the pain modulation. 
Another potential explanation for the effects of control is the meaning or 
significance of the pain in a given situation or its inferred cause (Arntz & Schmidt, 
1989; Thompson, 1981). This can be illustrated in reference to Beecher's (1956) 
investigations of pain in soldiers. Compared to a civilian group with equal injuries, 
soldiers reported less pain. Beecher argued that, for the soldiers, the wounds had 
a positive meaning in that they had to recover at home and could escape from 
direct involvement in battles, whereas no positive meaning was bound to the 
injuries of civilians (Thompson, 1981). Further, when a pain is controllable, its 
meaning is changed as the pain or its cause is no longer appraised as seriously 
harmful or threatening (Arntz & Schmidt, 1989). One of the most accepted 
explanations for the effects of control on pain was posed by Miller (1979) who 
suggested the minimax hypothesis, referring to attribution theory: “A person who 
has control over an aversive event insures having a lower maximum danger than a 
person without control. This is because a person with control attributes the cause 
of relief to a stable internal source–his own response–whereas a person without 
control attributes relief to a less stable, more external source” (p. 294). This means 
that having control minimizes the potential maximum harm one can experience 
because it guarantees a stable and internal attribution of agency.  
Along these lines, Wiech et al. (2006) found evidence that during self-controlled 
painful stimulation the right anterolateral PFC was activated, a brain area related 
to voluntary (i.e., conscious) (re)appraisal, at the same time the subjectively 
perceived intensity of the pain experience was reduced. Further imaging studies 
indicate that during uncontrollable compared to controllable painful stimulation, 
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brain areas typically associated with pain processing (primary somatosensory 
cortex, SI; anterior cingulate cortex, ACC; thalamus; insula; periaqueductal grey, 
PAG; PFC; Apkarian, Bushnell, Treede, & Zubieta, 2005) show increased activation, 
even if subjective ratings indicate no difference (Helmchen, Mohr, Erdmann, 
Binkofski, & Büchel, 2006; Mohr, Binkofski, Erdmann, Büchel, & Helmchen, 2005; 
Mohr, Leyendecker, & Helmchen, 2008; Salomons, Johnstone, Backonja, & 
Davidson, 2004). Also, subjects reporting increased pain during uncontrollable 
compared to controllable conditions show increased activity in pregenual ACC, 
PAG, and posterior insula, and secondary somatosensory cortex (SII; Salomons, 
Johnstone, Backonja, Shackman, & Davidson, 2007). Evidence suggests that the 
ACC may play a modulatory role for contextual information in the pain experience 
(placebo: Petrovic, Kalso, Petersson, & Ingvar, 2002; control: Salomons et al., 2004; 
cognitive modulation: Bantick et al., 2002; Petrovic & Ingvar, 2002). Further, the 
PAG is known to play a major role in descending pain modulation (Gwilym et al., 
2009; Porreca, Ossipov, & Gebhart, 2002; Yoshida, Seymour, Koltzenburg, & Dolan, 
2013). However, previous studies did not differentiate whether increased brain 
activation stemmed from augmented pain sensations or rather reflected 
modulatory influence. 
Clinical relevance of perceived control 
Controllability is important in acute (e.g., dental pain, childbirth training; Arntz & 
Schmidt, 1989; Thrash, Marr, & Box, 1982) as well as in chronic pain. Although it is 
not conclusively established which processes mediate the pain increase caused by 
uncontrollability or accordingly pain decrease caused by controllability, it seems 
unequivocal that lack of control potentially leads to learned helplessness and 
passivity (Müller, 2012), depression, and anxiety in the long term. Chronic pain and 
affective disorders often occur comorbid and lack of control is known to play a role 
in both disorders (Jensen & Karoly, 1991; Seligman, 1975). Chronic pain is strongly 
correlated with beliefs in the lack of ability to self-control pain (Philips, 1987) and 
generalized perceptions of no control (external locus of control, chance; Arntz & 
Schmidt, 1989). Learned helplessness (Abramson et al., 1978) can result in 
avoidance behavior which is a major factor in the maintenance of chronic pain 
(Samwel, Kraaimaat, Crul, & Evers, 2007; Vlaeyen & Linton, 2000). Animal research 
also shows that uncontrollable painful stimulation not only results in learning 
deficits (Mineka & Hendersen, 1985) but further in reduced food and water intake, 
exaggerated fear, fear conditioning, and reduced social interaction, amongst 
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others (Maier & Watkins, 1998) – signs reminding of symptoms in depression and 
anxiety disorders (Maier & Watkins, 2005).  
A model explaining the relation between lack of control, pain becoming chronic, 
and other consequences was proposed by Arntz & Schmidt (1989). They 
hypothesize that chronic pain patients formerly experienced a high level of control 
over their physical functioning. For these patients, an acute pain event thus 
constitutes a major loss of control, which can be more stressful than never having 
had control at all (Crombez et al., 2008; Janssen et al., 2004; Staub et al., 1971). 
Additionally, chronic pain patients are known to oftentimes strive for total pain 
relief, which inevitably leads to continued failures and thus helplessness. A vicious 
circle between low perceived control and the experience of pain and depression 
potentially develops.  
Therapeutic strategies usually have the goal to increase control and diminish the 
experience of pain, or increase perceptions of control. For example, in patient-
controlled analgesia (PCA), patients in acute pain conditions (e.g., post-operative 
pain) get the opportunity to self-administer analgesic medication as needed and 
thereby control time point and amount of the drug administration. Evidence 
shows that due to PCA, the intake of analgesics after operations could be 
significantly reduced (Bennett et al., 1982). An alternative approach to deal with 
the issue of uncontrollability in many pain conditions is taken in the currently 
popular acceptance and commitment therapy (ACT; Hayes, Strosahl, & Wilson, 
1999). Due to the fact that repeated, unsuccessful attempts to completely control 
pain (e.g., medication intake, avoidance of pain-inducing activities) can result in 
chronic vigilance to pain, further aggravating the condition (Crombez et al., 2008), 
the focus should be shifted away from the goal to control pain. The first and most 
important step in treating chronic pain according to ACT is to truly accept the pain 
before learning coping strategies (McCracken, 2004).  
 
1.3 Methods of Pain Assessment 
Pain is a multidimensional experience (Melzack & Wall, 1965) that can be assessed 
in different response channels, which do not necessarily have to correspond 
(Becker et al., 2011; Hölzl, Kleinböhl, & Huse, 2005). For example, a subject with 
back pain may subjectively rate the intensity of his pain as moderate, feel that it is 
highly aversive and that it will never get better, have a pain-specific facial 
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expression, and take a relieving posture or try to avoid certain movements. At the 
same time, this person might show increased skin conductance and muscular 
tension and activation in brain areas associated with pain processing. Thus pain 
can evoke subjective-emotional, cognitive, behavioral, and physiological reactions. 
In past research, pain perception has mostly been studied by means of subjective 
ratings (e.g., verbal and numeric pain ratings). Although they are easily applicable 
and possess high face validity, subjective ratings have been criticized for a number 
of reasons. They depend on verbal report and can consequently only assess the 
conscious, reportable part of the pain perception. Further, they are prone to 
demand characteristics (“answers of politeness and experimental subordination”, 
p. 1314, Kienle & Kiene, 1997; Hrobjartsson & Gotzsche, 2001) and it is not clear 
after experimental manipulations whether the perception of the subjects or only 
their response criteria or categories have changed (Chapman et al., 1985). This can 
even happen in experimental situations without awareness for the object being 
evaluated (e.g., blindsight; Cowey, 2004). This suggests that subjective ratings 
(alone) might not be ideally suited to assess the complex experience of pain. 
Pain assessment via other response channels (e.g., behavioral) is oftentimes 
neglected because subjective pain ratings are thought of as being sufficient. 
Further, behavioral responses can be more difficult to implement in an 
experimental procedure. A behavioral measure, i.e., discriminative behavior, is a 
behavioral response to a change in sensory input or subjectively experienced 
change in sensation (Becker, 2009; Hölzl et al., 2005). It does not depend on verbal 
mediation (e.g., on an instruction) and might therefore be an alternative to 
subjective ratings that can open up another perspective. With a behavioral 
measure, changes in pain perception might be observed that did not reach 
awareness in the subjects and would thus be missed in subjective ratings (Becker 
et al., 2011; Cowey, 2004). In blindsight, for instance, subjects are not aware of a 
visually presented stimulus and report that they did not see anything. However, in 
a performance test they can react accurately to the stimulus. Disadvantages of the 
subjective ratings, like demand characteristics, do not apply to discriminative 
behavior because the subjects are not necessarily aware that their responses serve 
as a measure of their perception. However, other than a subjective pain rating, 
discriminative behavior as defined above assesses changes in perception. This 
allows tracking of the dynamics of the pain perception as it develops over time. In 
previous studies, discriminative behavior served as a measurement for perceptual 
sensitization or habituation to tonic heat-pain stimulation and thereby implicitly 
indicating changes in pain perception. Subjective ratings, on the other side, 
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remained constant, suggesting that both response channels dissociated over time 
(Becker et al., 2011; Becker, Kleinböhl, & Hölzl, 2012; Hölzl et al., 2005; Kleinböhl 
et al., 1999).   
Besides subjective ratings and behavioral measures, the pain experience can 
further be investigated by exploring its neural (e.g., electroencephalography; 
functional Magnetic Resonance Imaging, fMRI; magnet encephalography) and 
physiological correlates (e.g., heart rate, skin conductance). Although these 
measures cannot be equated with the pain perception itself, they can give insight 
into the mechanisms of pain processing, serve as correlate for the emotional 
dimension of pain, and help to quantify associated aspects of the pain experience, 
like anxiety (Chapman et al., 1985). A better understanding of the relationship 
between psychological and physiological factors will help in understanding pain 
and lead to better treatment options (Turk & Okifuji, 2002). 
 
1.4 Aims of This Thesis  
The studies presented in this thesis deal with the investigation of two pain 
facilitating factors, namely conditioned nocebo responses and uncontrollability, 
and their effect on different response channels. The influence of cognitive factors 
on pain perception is widely recognized, but the specific mechanisms of nocebo 
effects and uncontrollability remain unclear to a large extent. Further exploring 
those mechanisms contributes to our understanding of pain processing in healthy 
individuals as well as the development and maintenance of clinical pain conditions 
and possible ways to prevent the pain facilitating impact of both the nocebo effect 
and uncontrollability.  
An overview over the single studies and their respective aims are given in Figure 1. 
In particular, the following specific aims were addressed: 
Classical conditioning of a nocebo effect  
In study 1, a nocebo effect in both a subjective-verbal and an implicit-behavioral 
response channel will be induced by classical conditioning to confirm the notion 
that verbal suggestions are not essential in inducing a nocebo effect in the 
nociceptive system.  
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Induction of nocebo-hyperalgesia by classical conditioning and analysis of 
autonomic responses and personality traits 
In Study 2, the classical conditioning procedure, which was developed in Study 1, 
will be adapted in order to induce nocebo-hyperalgesia. Further, the effect of 
nocebo conditioning on heart rate and heart rate variability, as indicators of the 
autonomic activity, will be measured. In order to better characterize nocebo 
responders, motivational style and suggestibility will be assessed besides anxiety. 
Exploration of the role of contingency awareness in nocebo conditioning 
Classical conditioning can occur with and without contingency awareness (i.e., 
knowledge concerning the relation between CS and US). Although a recent study 
shows that a nocebo effect can be activated by subliminally presented cues after 
explicit conditioning (supraliminal CS presentation, Jensen et al., 2012), it is not 
known whether implicit conditioning (i.e., without contingency awareness) can 
induce a nocebo effect, which would support the notion that explicit expectations 
are not necessary for the nocebo effect to occur. Therefore, in both Studies 1 and 
2, the role of contingency awareness and CS differentiation will be explored. 
Investigation of the effect of stimulus uncontrollability on pain perception and 
its neural correlates 
Although studies showed increased activity in pain processing brain areas during 
uncontrollable compared to controllable painful stimulation, it is not known which 
brain regions drive uncontrollability-induced pain augmentation. In Study 3, a 
yoked-control design will be developed to compare neural correlates of 
controllable and uncontrollable pain stimulation of the same intensity and 
investigate uncontrollability-induced pain sensitization during fMRI. 
Methodological Aims  
Methodological aims of this thesis comprise the assessment of pain-modulatory 
effects in both subjective-verbal and implicit-behavioral response channels. 
Further, a classical conditioning procedure will be developed to induce a nocebo 
effect. Instead of conventional artificial experimental stimuli, thermal stimuli will 
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serve as conditioned (CS) and unconditioned stimuli (US). Thereby we will take 
advantage of preparedness and natural stimulus relations, as both CS and US 
derived from the somatosensory domain. Another methodological aim is the 
development of a procedure to induce uncontrollability after the subject exerted 
instrumental control over the applied stimulus intensities. Here, a continuous 
subjective rating shall be implemented in order to uncover the pain enhancing 
effects and allow correlation with neural activity. 
 
 
Figure 1: Overview of the studies and their respective aims. See text for details. 
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2. Conditioned Nocebo Effects in Heat-Pain Perception 
2.1 Classical Nocebo-Conditioning of Heat-Pain Perception: 
Dissociation of Subjective Rating and Implicit Behavioral 
Response  
 
Introduction 
Placebo effects have been widely studied over the past few decades. However, 
their adverse counterpart, so-called nocebo effects, received far less attention 
(Benedetti et al., 2006). They range from feeling sick after applying an inactive 
substance or procedure to experiencing severe symptoms (Witthöft & Rubin, 
2013), which may even lead to life-threatening conditions (Cannon, 2002). 
Understanding the different underlying mechanisms is highly relevant in a clinical 
context as nocebo effects may worsen symptoms and diminish therapy outcome 
(Amanzio, Corazzini, Vase, & Benedetti, 2009; Barsky, Saintfort, Rogers, & Borus, 
2002; Benedetti et al., 2007; Colloca & Miller, 2011; Hahn, 1997). Nocebo 
mechanisms have been most widely studied in the context of pain, where they can 
cause hyperalgesia due to receiving an inert substance or procedure (Stewart-
Williams & Podd, 2004).  
As main mechanisms causing nocebo-hyperalgesia, psychological processes such 
as conscious expectation and classical conditioning are discussed (Enck, Benedetti, 
& Schedlowski, 2008; Pacheco-Lopez, Engler, Niemi, & Schedlowski, 2006; Stewart-
Williams & Podd, 2004). Further, anxiety is assumed to play a role by activating the 
CCK-system, which in turn leads to pain increase (Benedetti et al., 2006). Evidence 
shows that conscious (i.e., reportable, Stewart-Williams & Podd, 2004) 
expectations induced by verbal instruction or explicit suggestions can result in 
increased reports of pain despite unchanged stimulation intensities (Benedetti et 
al., 2003; Colloca et al., 2008; van Laarhoven et al., 2011). However, recent results 
indicate that nocebo-hyperalgesia can also be learned without inducing conscious 
expectation (Jensen et al., 2012). Even more impressive, learned nocebo effects 
can be activated by masked cues, i.e., non-consciously perceived, previously 
neutral stimuli (Jensen et al., 2012). This learning mechanism and the non-
conscious activation of nocebo effects appear to be particularly relevant in the 
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clinical context. For example, certain aspects of medical environments (e.g., the 
examination room) can serve as cues getting associated to pre-existing, ambiguous 
symptoms (random headache) or painful measures (taking blood samples, 
injections) and inadvertently trigger enhanced pain later on. Although one study in 
the context of placebo effects suggests that placebo-hypoalgesia could not be 
induced by implicit conditioning (Martin-Pichora, Mankovsky-Arnold, & Katz, 
2011), it remains unclear whether a person has to be aware of the contingencies 
(i.e., recognize the relationship between cue and symptom) to learn and thus 
develop a nocebo effect. The significance of contingency awareness is critically 
debated in classical conditioning, as it seems to be necessary for successful 
learning in certain conditions, like delay conditioning, whereas not in others, like 
trace conditioning (Clark et al., 2002; Manns et al., 2001; Manns et al., 2002; 
Perruchet, 1985).  
In most studies, nocebo-hyperalgesia has been investigated exclusively by using 
subjective pain reports. Although an important assessment of pain, subjective pain 
reports are prone to response bias (Cowey, 2004) and it is conceivable that 
subjective nocebo effects are caused (partly) by changes in response criteria 
(Hrobjartsson & Gotzsche, 2001; Kienle & Kiene, 1997). Supporting this notion, it 
has been shown that learning can lead to a dissociation of subjective sensation 
(explicit judgment of sensation) and indirectly (behaviorally) assessed perception 
(implicit judgment by discriminative responses; Becker et al., 2011; Hölzl et al., 
2005). Similarly, nocebo effects observed in physiological correlates or secondary 
indicators of pain (e.g., cortisol) are not necessarily reflected in subjective 
measures (Johansen et al., 2003), emphasizing that pain is not a one-dimensional 
phenomenon. Accordingly, it is not known which behavioral consequences arise 
from nocebo effects although this could have important clinical implications. For 
example, it is known that certain behavioral responses to pain, e.g., short-term 
relieving and protective postures as escape and/or avoidance behavior, often 
unnoticed and involuntary, can lead to enhanced pain sensitivity and—in the long 
run—to augmented clinical pain and pain becoming chronic (Flor, Birbaumer, & 
Turk, 1990; Fordyce, 1976). Therefore, in order to understand the mechanisms of 
nocebo-hyperalgesia and its possible role in symptom worsening and chronic pain, 
different response channels have to be considered.  
The aims of this study were to a) classically condition nocebo responses in 
subjectively assessed heat-pain perception, b) specify the relation of the 
conditioned nocebo effect to contingency awareness, c) explore short-term 
changes of heat-pain sensation assessed with implicit behavioral and subjective 
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measures (Becker et al., 2011; Hölzl et al., 2005) in response to conditioned 
nocebo-hyperalgesia, and d) examine the role of anxiety measures (state and trait 
anxiety; anxiety specifically related to pain). We hypothesized that a nocebo 
effect. Further, a positive correlation of the nocebo effect with anxiety measures 
was expected. 
 
Methods 
Subjects 
Twenty-six healthy volunteers (12 females; age: M = 24.1 years, SD = 4.2 years) 
participated after screening for the following exclusion criteria: chronic pain 
(longer than three month or more than once a month for longer than three days) 
or acute pain, intake of analgesics or psychotropics, chronic disease (diabetes, 
hypertension, cardiopathy, thyroid disease, renal insufficiency, hepatic 
dysfunction, epilepsy, stroke, Parkinson’s disease, multiple sclerosis), psychiatric or 
neurologic diagnoses, intake of recreational drugs, substance or alcohol abuse, 
pregnancy, and left-handedness (tested with the Edinburgh Handedness 
Inventory; Oldfield, 1971).  
The experimental protocol was conducted in accordance with the revised 
Declaration of Helsinki and approved by the Local Ethics Committee (2010-226N-
MA). All subjects gave informed consent prior to experimental testing.  
Conditioning procedure 
Subjects took part in one experimental session of approximately 45 min duration, 
during which the conditioning procedure was performed. Within each single trial, a 
conditioned stimulus (CS) was directly followed by an unconditioned stimulus (US; 
Figure 2), specifying a border case of delay conditioning (without overlap of CS and 
US) and trace conditioning (with a trace of 0 seconds).  
The procedure was divided into a learning and a test phase. Two different thermal 
stimuli served as CS (see section 2.6); one served as the so-called CS– and 
contingently preceded the presentation of a non-painful unconditioned 
temperature stimulus (USno pain; see section 2.5). The other served as the so-called 
CS+ and contingently preceded the presentation of a painful unconditioned 
temperature stimulus (USpain; see section 2.5) in the learning phase. The two 
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different CS and accordingly the two different US were each presented in 15 trials 
in the learning phase (duration of a single trial: approximately 1 minute). In the 
test phase, both the CS+ and CS– preceded USno pain in five trials each, to test for 
conditioned nocebo responses to the CS+. Consequently, USpain was not presented 
during the test phase. The trial order in the learning and test phases and thereby 
the sequence of CS+/CS– presentations was pseudo-randomized with the 
constraint of no more than three subsequent presentations of the same CS.  
Rating scale 
During the experiment, the subjects employed a visual analog scale (VAS) to 
indicate their sensation. The scale was vertically oriented and incorporated the 
sensation of temperature and pain (Kleinböhl, Trojan, Konrad, & Hölzl, 2006; 
Lautenbacher, Möltner, & Strain, 1992), being labeled with 0 – ‘warm’ at the 
bottom and 100 ‘very strong pain’ at the top. At a scale value of 40, an additional 
anchor was included, labeled ‘just painful’. The VAS was open at the upper end to 
avoid ceiling effects and subjects were familiarized using the VAS prior to the 
experimental testing. 
Course of a conditioning trial 
Each trial (Figure 2) started with the presentation of either the CS+ or the CS– 
(duration: 5 s). Following that, the stimulation intensity rose until it reached the 
designated temperature of either the USpain or the USno pain (see section 
“Unconditioned Stimuli”). When the target temperature was reached, subjects 
rated their current subjective pain sensation on the VAS (VAS1). Subsequently, the 
subjects performed a self-regulation procedure (duration: 25 s) in order to 
implicitly assess changes over time in subjective perception of the tonic stimulus 
with a behavioral response. As the CS was no longer present during this procedure, 
this behavioral response depicts the decomposition of the “exaggerated” 
subjective sensation over time and is interpreted as behaviorally assessed “decay” 
of the conditioned nocebo response. During the self-regulation procedure, the 
subjects were told to keep the temperature constant by antagonizing any 
perceived temperature change with a response unit (turning the wheel of a 
computer mouse up or down). Because the temperature did in fact not change 
other than when the subject operated the response unit, any change perceived by 
the subject was interpreted as adaption (indicated by up-regulation of the 
temperature) or apparent (subjective) sensitization, probably due to temporal 
summation (indicated by down-regulation of the temperature). After 25 s, the 
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temperature returned to the initial level (of USpain or USno pain) and the subjects 
rated their current subjective sensation on a VAS for a second time (VAS2). 
Implementing this second subjective rating allowed us to explore an explicitly 
assessed indicator for change in subjective sensation (i.e., decay of the 
conditioned nocebo response over time, in the following called “subjective decay”) 
besides the behavioral decay operationalized in the self-regulation procedure. 
After the rating, the temperature returned to baseline and 5 –10 s later the next 
trial started. 
Unconditioned stimuli 
The intensities of the US were adjusted to the subjects’ individual pain thresholds 
that were assessed prior to the conditioning task with the method of production 
(Kleinböhl et al., 1999). Subjects increased the temperature themselves with the 
response unit, starting from baseline (34 °C) until they perceived the temperature 
as just painful. This assessment was repeated 3 to 6 times (taking into account 
inter-trial habituation processes). The just painful self-adjusted temperature of the 
last trial was employed as the pain threshold (Kleinböhl et al., 1999). 
Two different temperatures served as US: pain threshold + 1.5 °C (USpain) and pain 
threshold –2.2°C (USno pain). The temperatures for both US were based on the pain 
threshold plus or minus four units of just noticeable differences (i.e., 0.37 °C above 
or accordingly 0.54 °C below the pain threshold; Bushnell, Duncan, Dubner, Jones, 
& Maixner, 1985; Maixner et al., 1986; Maixner, Dubner, Bushnell, Kenshalo, & 
Oliveras, 1986; Maixner, Dubner, Kenshalo, Bushnell, & Oliveras, 1989). With this 
approach we wanted to achieve that the two US temperatures were equally far 
away from the pain threshold in subjective perception although they were not 
equidistant physically.  
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Figure 2: Trial structure. The trial started at baseline temperature (34 °C) and increased or 
decreased to the temperature set for the conditioned stimulus (CS; 32 °C or 36 °C). After 5 
s, it increased to the preset level of the non-painful (USno pain; individual pain threshold – 
2.2 °C) or painful unconditioned stimulus (USpain; individual pain threshold + 1.5 °C), 
depending on the respective assignment (dotted lines). The subject rated the currently 
perceived stimulus intensity on a visual analog scale (VAS1). Then, the self-regulation 
procedure started (T1, initial temperature), where the subject was told to keep the 
temperature constant for 25 s by operating the wheel of a computer mouse inducing 
cooling and heating. Depicted is an example of temporal summation after presentation of 
USpain where the subject decreased the temperature over time and an example of adaption 
after presentation of USno pain where the subject increased the temperature. The difference 
of the initial temperature (T1) and self-adjusted end temperature (T2) operationalized the 
cumulated, implicitly assessed change in sensation (“behavioral response”, interpreted as 
behaviorally assessed decay of the conditioned nocebo response, please refer to section 
“Course of a Conditioning Trial”). After the self-regulation procedure, the temperature 
returned to the initial intensity (T1) and the subject rated the currently perceived stimulus 
intensity on a visual analog scale (VAS2) for a second time. The difference between VAS2 
and VAS1 operationalizes the explicitly assessed change in sensation (“subjective decay”). 
In the end, the temperature returned to baseline level before the next trial started. 
 
Conditioned stimuli 
Two different thermal stimuli were applied as CS; one CS had a temperature of 36 
°C and the other had a temperature of 32 °C (baseline temperature +/– 2 °C). The 
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duration of the CS was five seconds. The coupling of the two CS with the two 
different US was balanced across subjects. Non-painful CS of the same modality as 
the painful US were used to incorporate preparedness (i.e., evolutionary 
advantage; Seligman, 1970) and natural relations (belongingness) instead of 
arbitrary coupling of CS and US (Domjan, 2005). Due to the interoceptive nature of 
pain (Craig, 2003), it was assumed that subjects were conditioned more likely to 
somatosensory (i.e., proximal body) rather than exteroceptive (i.e., distal) and 
artificial, experimental cues (i.e., colored squares or circles). 
Apparatus for stimulus application 
The experimental stimuli were applied with a contact heat thermode (25x50 mm; 
SENSELab-MSA Thermotest, SOMEDIC Sales AB, Sweden). The thermode system 
allows for phasic and tonic stimulation within a temperature range from 10 to 52 
°C with a relative accuracy of 0.02 °C. The baseline temperature during the 
experiment was 34 °C. The rate of temperature change was 0.7 °C/s, except at the 
end of a trial where the temperature returned to baseline with a rate of 3 °C/s. 
The thermal stimuli were presented to the thenar eminence of the subject’s left 
hand. To prevent skin damage, the maximum temperature was limited to 50 °C 
and total applied energy was restricted by integrating temperature over time. The 
procedure was terminated if a critical value was reached. This value was calculated 
according to human and animal data on skin burns through contact heat 
(Brennum, Dahl, Moiniche, & Arendt-Nielsen, 1994; Dahl, Brennum, Arendt-
Nielsen, Jensen, & Kehlet, 1993; LaMotte, 1979; Pedersen, Andersen, Arendt-
Nielsen, & Kehlet, 1998). The experimental procedures were automatized and 
controlled by a separate personal computer coupled to the thermostimulator 
system. A computer screen in front of the subject displayed instructions and rating 
scales. A computer mouse with two buttons and a mouse wheel served as 
response unit. 
Post-experimental interview & anxiety measures 
After the conditioning task, subjects were interviewed in order to assess whether 
they distinguished the two different CS and recognized the relationship between 
the CS and US, i.e.,, if they developed contingency awareness. For this purpose, 
subjects were shown a flowchart of the time course of one trial that had already 
been used during instruction. The flowchart depicted a temperature course and 
showed the trial sections “first temperature change” (i.e CS), “second temperature 
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change” (i.e., US), “first temperature rating” (i.e., VAS1), “temperature 
maintenance interval” (i.e., self-regulation procedure), and “second temperature 
rating” (i.e., VAS2). In order to assess successful CS+/CS– differentiation, subjects 
were asked if they had felt different temperatures in different trials during “first 
temperature change”. Then they were asked whether the non-painful/painful 
“second temperature change” usually followed the warmer/colder stimulus and 
whether the colder/warmer stimulus predicted non-painful/painful “second 
temperature change”. In case of negation, we inquired if there could have been 
any relation between the first and second temperature change, in particular, if one 
stimulus usually followed another or not.  
At the end of the testing session, subjects completed both the state and trait part 
of the State-Trait Anxiety Inventory (STAI; Spielberger, 1970), the Fear of Pain 
Questionnaire (FPQ; McNeil & Rainwater, 1998) and the Pain Anxiety Symptoms 
Scale (PASS; McCracken, Zayfert, & Gross, 1992). 
Statistical analysis  
Five subjects had to be excluded from the analyses because they did not perceive 
the USpain as painful, resulting in 21 subjects (9 females; age: M = 24.4 years, SD = 
4.56 years) in the statistical analyses. 
In order to test for conditioned nocebo effects, only subjective ratings during the 
test phase were considered (differential responses to trials cued with CS+ or CS–). 
However, to investigate whether potential confound variables were related to the 
nocebo effect and might explain differences in conditioning success, different 
indices derived from the learning phase (e.g., characterizing a priori differences 
between subjects or effects of the conditioning) were incorporated and served as 
additional factors or covariates, at first. Due to the significant impact of one 
covariate on the nocebo effect (rating of painful trials during the learning phase), 
the subjective ratings (VAS1) of the test phase were adjusted accordingly by using 
the fitted values of the analysis of covariance for further analyses. After confirming 
the normal distribution of the residuals (Curran, 1996; Hair Jr, Anderson, Tatham, 
& Black, 1998), linear mixed models (LMM) with two fixed within-subject factors, 
‘CS’ (CS+, CS–) and ‘time’ (5 trials), were used to assess the effects of the learning 
procedure. The intercept of ‘time’ served as random factor. Post hoc tests (Fisher 
least significant differences, LSD) were calculated to compare trials cued with CS+ 
and CS– across the course of the test phase where appropriate. 
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Indicators of subjective decay (i.e., difference between the second first subjective 
rating; VAS2 – VAS1) and behavioral response (i.e., difference between self-
adjusted temperature in the end of each trial and initial temperature; T2– T1) 
served as dependent variables within the above described LMM. Further, T-tests 
and Pearson’s correlations were calculated where appropriate.  
Post hoc, subjects were divided into subgroups of either successfully conditioned 
subjects (learners) or subjects who showed no conditioned responses (non-
learners). Subjects were considered learners, when they, on average, evaluated 
the temperature following CS+ as higher compared to the temperature following 
CS– in the test phase (VAS1). The learner subgroup, as allocated according to the 
subjective rating, was further investigated in regards to the behavioral measure, 
enabling an independent application of the specified learner criterion and thus 
avoiding circular reasoning (Kriegeskorte, Simmons, Bellgowan, & Baker, 2009). 
In order to test whether the nocebo effect was independent of contingency 
awareness and CS differentiation, regression analyses were calculated, in which 
contingency awareness and CS differentiation, respectively, predicted the size of 
the subjective nocebo effect (Becker et al., 2012; Dienes, 2008; Greenwald, 
Klinger, & Schuh, 1995). The intercept estimated the size of the subjective nocebo 
effect without awareness and CS differentiation, respectively, and the slope 
indicated whether awareness and accordingly CS differentiation were conducive to 
the effect. 
The significance level was set to 5%. Figures were prepared in R 2.8 (R 
Development Core Team, 2010) and statistical tests were calculated in SPSS 21. 
 
Results  
Manipulation check 
The mean pain threshold of the subjects was 43.4 °C (SD = 2.64), resulting in 
average stimulus temperatures of 41.2 °C for the non-painful and 44.9 °C for the 
painful US. Subjects clearly distinguished between the painful (M = 60.8, SD = 
15.72) and non-painful US (M = 8.5, SD = 9.17) in the subjective rating during the 
learning phase (VAS1; main effect ‘CS’: F (1, 64.3) = 1020, p < .001). The ratings 
increased over time (Figure 3A; main effect ‘time’: F(14, 194.9) = 2.52, p = .002), 
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which was more the case for the painful trials (interaction effect ‘CS x ‘time’: F(14, 
242.3) = 7.01, p < .001), indicating sensitization across trials. 
Possible confound variables related to the nocebo effect 
We investigated whether the nocebo effect in the subjective ratings was 
influenced by a number of confounding variables. The following variables did not 
impact the nocebo effect in the subjective ratings:  
a) sensitization across trials during the learning phase (distinguishing 
sensitizers (beta ≥ .1; N = 10) from non-sensitizers (beta > .1; N = 11) by 
predicting the subjective ratings of the painful stimulation over time 
during the learning phase in regression analyses for each subject; main 
effect ‘sensitization’: F(1, 20.8) = .74, p = .399;  interaction effect ‘CS’ x 
‘sensitization’: F(1, 39.7) = .79, p = .379); 
b) distribution of subjective ratings of the painful trials during the learning 
phase (classifying subjects according to their deviation from the Gaussian 
distribution, for more details please refer to Figure SI A in the Appendix; 
main effect ‘deviation’: F(1, 20.9) = 1.03, p = .322; interaction effect ‘CS’ x 
‘deviation’: F(1, 39.4) = 1.05, p = .313); 
c) pain threshold (main effect ‘pain threshold’: F(1, 91.4) = 18.4, p < .001; 
interaction effect ‘CS’ x ’pain threshold’: F(1, 128.8) = 0.46, p = .497); 
d) average difference in adaptation between non-painful and painful trials on 
an individual basis during the learning phase (main effect ‘adaptation’: F(1, 
94.4) = 0.27, p =.606; interaction effect ‘CS’ x ‘adaptation’: F(1, 125.5) = 
4.87, p = .029);  
e) difference in subjective ratings between non-painful and painful trials 
during the learning phase (main effect ‘VAS difference’: F(1, 94.8) = 2.79, p 
=.098); interaction effect ‘CS’ x ‘VAS difference’: (F(1, 124.6) = 13.92, p < 
.001);  
f) degree of temporal summation or adaption in response to painful trials 
(CS+) during the learning phase (main effect ‘adaptation CS+’: (F(1, 94.2) = 
2.04, p =.157; interaction effect ‘CS’ x ’ ‘adaptation CS+’: F(1, 127.2) = 
0.911, p = .342).  
Finally, including the subjective rating of the painful trials during the learning 
phase led to a main effect (main effect ‘US rating’: F(1, 88.6) = 51.6, p < .001) as 
well as an interaction effect (interaction effect ‘CS’ x ‘US rating’: F(1, 125.5) = 30.1, 
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p < .001). In order to account for this variance induced by the perception of painful 
trials in the learning phase, we used the fitted values of subjective ratings for the 
following analyses. 
 
 
Figure 3: Subjective ratings (VAS1) throughout the experiment. Depicted are subjective 
ratings (mean and standard errors of mean) of trials cued with CS+ (black) and CS– (grey) 
during the learning phase (A) and the test phase (fitted values, adjusted for differences in 
the rating of the painful stimuli during the learning phase; B) of the whole sample (N = 21) 
and during the test phase of the learner subgroup (C; N = 13), and non-learner subgroup 
(D; N = 8). The dashed line depicts the pain threshold (VAS = 40). 
 
Nocebo effects in subjective ratings 
A nocebo effect in the subjective ratings (fitted values, see section “Statistical 
Analysis”) was observable in the test phase: the same stimulation intensity was 
rated higher when cued by the CS+ (initially coupled to USpain) compared to the CS– 
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(initially coupled to USno pain; main effect ‘CS’: F(1, 39.8) = 5.37, p = .026; Figure 3B). 
Further, subjective responses increased over time (main effect ‘time’: F(4, 86.5) = 
4.64, p = .002), but this was not different for the two CS (interaction effect ‘CS’ x 
‘time’: F(1, 95.1) = 1.04, p = .393). 
Fifteen out of 21 subjects (71.4 %) were successfully conditioned as identified by 
larger ratings of the temperature (VAS1) when cued by CS+ compared to CS– 
(Figure 3C; please also refer to the non-learners in Figure 3D). Subjective ratings 
did not change across trials during the test phase (main effect ‘time’: F(1, 82.7) = 
1.18, p < .328). An interaction effect (Figure 3C; interaction effect ‘CS’ x ‘time’: 
F(4,80.8) = 4.63, p = .002; main effect ‘CS’: F(1, 80.8) = 67.6, p < .001) indicated 
that extinction occurred, which was confirmed by post hoc tests (trial 1: LSD = 6.8, 
p < .001; trial 2: LSD = 3.9, p = .005; trial 3: LSD = 8.2, p < .001; trial 4: LSD = 5.3, p < 
.001; trial 5: LSD = 0.7, p = .621).  
Subjective decay of the nocebo response 
For an illustration of the subjective ratings after the self-regulation procedure 
(VAS2), please refer to Figure SII in the Appendix. 
To explore how the subjective sensation developed over time within trials, the 
difference between VAS2 and VAS1 was calculated. In the learning phase, negative 
values for trials cued with CS+ indicated that the second subjective rating was 
smaller than the first subjective rating within one trial, whereas no difference 
between first and second rating was observable for trials cued with CS– (Figure 4A; 
main effect ‘CS’: F(1, 120.5) = 8.9, p = .003). The difference in the ratings changed 
across the learning phase (Figure 4A; main effect ‘time’: F(14, 220.1) = 3, p < .001). 
Further the interaction effect (interaction effect ‘CS’ x ‘time’: F(14, 266.7) = 4.48, p 
< .001), which depended on increasingly negative differences between VAS2 and 
VAS1 within CS+ but not CS– trials, indicated increasing subjective decay of the 
conditioned nocebo response over time (i.e., across the trials). 
In the test phase, the difference in subjective ratings indicated increased 
subjective decay for trials cued with CS+ compared to CS–, as well (Figure 4B; main 
effect ‘CS’: F(1, 141.1) = 12.67, p = .001). There was neither a change across trials 
(main effect ‘time’: F(4, 169.4) = 0.6, p = .663) nor an interaction effect (interaction 
effect ‘CS’ x ‘time’: F(4, 141.1) = 0.2, p = .938), suggesting that this difference 
depending on CS type was stable. This pattern of results was confirmed when only 
testing the learner subgroup (Figure 4C; main effect ‘CS’: F(1, 99.3) = 11.76, p = 
2. Conditioned Nocebo Effects in Heat-Pain Perception 
31 
.001; main effect ‘time’: F(4, 117.2) = 0.41, p = .802; interaction effect ‘CS’ x ‘time’: 
F(4, 99.3) = 0.26, p = .905). 
 
 
Figure 4: Subjective decay of the conditioned nocebo effect (VAS2 – VAS1) throughout the 
experiment. Depicted are the differences in subjective ratings (means and standard errors 
of mean) of trials cued with CS+ (black) and CS– (grey) during the learning phase (A) and 
test phase (B) of the whole sample (N = 22) and during the test phase of the learner 
subgroup (C; N = 11) and non-learner subgroup (D; N = 11). 
 
Self-regulation procedure 
In the test phase, for the whole sample, no difference in response to trials cued 
with CS+ and CS– was apparent in the behavioral response (main effect ‘CS’: F(1, 
131.5) = 2.07, p = .153) and there was no change over time (main effect ‘time’: F(4, 
176.2) = 1.17, p = .324; interaction effect ‘CS’ x ‘time’: F(4, 131.5) = 0.08, p = .988). 
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For trials of both CS type, subjects’ behavioral responses indicated adaption to the 
stimulation (positive values; Figure 5B).  
When restricting the analysis to the learner subgroup, based on subjective ratings, 
analyses showed that they adapted more within trials when cued with CS+ 
compared to CS–, indicating a stronger decay of the conditioning effect during the 
trial (Figure 5C; main effect ‘CS’: F(1, 93.9) = 4.2, p = .043). No main effect of ‘time’ 
(F(4, 125.6) = 0.67, p = .615) and no interaction effect emerged (interaction effect 
‘CS’ x ‘time’: F(4, 93.9) = 0.04, p = .997), suggesting that the conditioned effect 
remained stable over time.  
 
 
Figure 5: Behavioral response (i.e., behaviorally assessed decay of the conditioned 
nocebo response) throughout the experiment. The y-axis represents the difference 
between self-adjusted end temperature and initial temperature of the subjective adaption 
procedure (mean and standard errors of mean) of the single trials cued with CS+ (black) 
and CS– (grey) during the learning phase (A) and test phase of the whole sample (B; N = 21) 
and the test phase of the learner subgroup (C; N = 13) and non-learner subgroup (D; N = 8).  
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In the learning phase, subjects showed more temporal summation in response to 
the painful trials as compared to non-painful trials (Figure 5A; main effect ‘CS’: F(1, 
447.7) = 16.7, p < .001). There was no main effect over time (main effect ‘time’: 
F(14, 524.7) = 1.3, p = .202;9) but the interaction indicated that over time (across 
trials) the degree of temporal summation decreased for the painful trials 
(interaction effect ‘CS’ x ‘time’: F(14, 440.4) = 1.8, p = .036). 
Contingency awareness and differentiation of CS temperatures 
Remarkably, fourteen out of 21 subjects (66.7 %) did not recognize the 
contingency between CS and US, i.e., could not tell if 32 or 36 °C was coupled to 
the higher US temperature. None of the subjects in the non-learner subgroup was 
aware of the contingency; however, only seven subjects out of the learner 
subgroup (46.7 %) were contingency aware, indicating that contingency awareness 
was not necessary for successful conditioning (effect size of contingency 
awareness: d = 0.27). The positive intercept in the regression analyses confirmed 
the notion that learning of a nocebo response was independent of contingency 
awareness. (Figure 7A; intercept = 7.6) Further, the slope (slope = -0.03) revealed 
that contingency awareness was neither helpful nor detrimental. 
 
 
Figure 7: Regression of nocebo effect in the subjective rating with contingency awareness 
(A) and differentiation of the conditioned stimuli (CS; B). Subjects were categorized as 
aware or unaware of the contingency between CS and US and either distinguished or could 
not distinguish between CS+ and CS−. The notch of the box plots displays the median and 
the length of the notched bar displays a confidence interval around the median. 
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Nine subjects out of 21 (42.9 %) stated in the interview after the experiment that 
they could not distinguish between CS− and CS+ (32 and 36 °C). Three subjects of 
the non-learner subgroup (60 %) and six subjects of the learner subgroup (40 %) 
could not distinguish the CS, indicating that conscious differentiation of the two CS 
was neither necessary nor sufficient for successful conditioning. However, the 
negative intercept in the regression analyses indicated that the subjective nocebo 
effect depended of CS differentiation (Figure 7B; intercept = -14.1) and the positive 
slopes further revealed that differentiation of the CS would have increased 
learning (slope = 0.28). 
Anxiety measures 
The subjective nocebo effect was not associated with state (r = -0.35, p = .116) or 
trait anxiety (STAI; r = -0.07, p = .766), fear of pain (FPQ; all p > .344) or fear and 
anxiety responses specific to pain (PASS; all p > .067), suggesting that differences 
in anxiety were not related to the learning success.  
 
Discussion 
The present results demonstrate successful learning of a nocebo effect, i.e., 
increased perception of nociceptive stimuli indicated by subjective ratings in a 
respondent learning procedure. In the absence of the nocebo cue, a decay of the 
nocebo response was observable in both the subjective and the behavioral 
responses (the latter only in the learner subgroup), indicated by increased 
adaption within the trial. The majority of subjects did not recognize a relation 
between the cues and the following stimulation and contingency awareness was 
not necessary for the nocebo effect to occur. However differentiation of the CS 
was beneficial. Contrary to our hypothesis, anxiety was not related to the 
subjective nocebo effect. 
To our knowledge, this is the second study to induce a conditioned nocebo effect 
without additional verbal suggestions or nocebo cues that are prone to induce 
expectations from the outset (Jensen et al., 2012). This demonstrates that 
conditioning is sufficient to generate a nocebo effect and conflicts with the 
hypothesis that learning is unimportant in nocebo-hyperalgesia, compared to 
placebo-hypoalgesia (Colloca et al., 2008). Further, for the first time, the short 
time development of sensation after having triggered a nocebo response was 
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investigated. In contrast to simultaneous or clear-cut trace conditioning, in which 
the CS would co-terminate with the US, the present conditioning paradigm, which 
was a borderline case of delay conditioning (without overlap of CS and US) and 
trace conditioning (duration of the trace between CS and US = 0) enabled us to 
observe the development of the conditioned response over time because the CS 
was directly followed by the US and did not overlap. Figuring that the conditioned 
nocebo response should decompose over a time range of a few seconds if the 
nocebo cue is no longer present, the increased adaption in subjective sensation 
was interpreted as decay of the nocebo response. In other words, the results 
suggest that the “exaggerated subjective perception” induced by the nocebo-
conditioning was reset shortly after it had been provoked.  
From this point of view, evidence for an increasing conditioning effect during the 
learning phase might be assumed: The sensitization across trials in VAS1 (i.e., 
increasing subjectively reported intensity) might be interpreted as partially caused 
by the conditioning in the face of the simultaneously increasing subjective decay, 
representing the nocebo portion of this sensitization. 
The decay of the nocebo response was observable in both the subjective and 
behavioral measure. Forming an explicit judgment and producing a communicable 
response requires many cognitive operations, which makes the process of 
subjective rating interference-prone for external influences, such as demand 
characteristics (Hrobjartsson & Gotzsche, 2001; Kienle & Kiene, 1997), judgment 
bias, and changes in response criteria (Cowey, 2004). However, the implicit 
behavioral measure does not depend on verbal mediation and thereby reduces the 
risk to confound changes in response criteria with changes in perception (Cowey, 
2004). The results indicate that the subjective nocebo effect was not solely caused 
by demand characteristics (Hrobjartsson & Gotzsche, 2001; Kienle & Kiene, 1997) 
as a nocebo effect was also observed in the behavioral measure; and during the 
self-regulation procedure subjects were not necessarily aware that their sensation 
was assessed (Hölzl et al., 2005). In addition to that, with the behavioral measure 
aspects of perception can be assessed that are not represented verbally (e.g., 
Becker, 2009; Gazzaniga, 2005; Weiskrantz, 2004). Accordingly, the results show 
that the subjective-verbal and implicit-behavioral response channels cover partly 
different aspects of perception, since the decay of the nocebo response, as 
assessed with the self-regulation procedure, was only apparent in the learner 
subgroup. This has important clinical implications because evidence shows that 
behavioral responses to changes in pain sensation can occur unnoticed by the 
patient (Becker et al., 2011; Hölzl et al., 2005) and contribute to increased pain 
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sensitivity in the long run. The investigated sample consisted of healthy subjects 
that showed a quick decay of the nocebo response, which could be interpreted as 
a resilience factor. However, it is conceivable that the decay of the nocebo 
response is deficient in patients with acute or chronic pain (e.g., 
delayed/decreased decay or prolonged nocebo response in subjective or 
behavioral assessment) and thereby further exacerbating pain sensitivity or 
promote adverse behavior (e.g., relieving postures). 
There are possible alternative explanations other than decay of the nocebo 
response for the observed pattern in the change of the subjective perception, 
which cannot be ruled out, yet not necessarily contradict our interpretation. The 
increased adaption in subjective perception following a nocebo response could 
depend on contrast effects (Gibson, 1937). As the size of the contrast effect 
depends on the initial value, it would be larger after subjectively increased pain 
perception (i.e., after CS+, when a subjective nocebo effect was induced) and 
consequently lead to a stronger decrease in perception compared to trials cued 
with CS–. Further, the decreased perception could be due to descending inhibition, 
an opposite process that might build up parallel to the nocebo induction, yet 
proceed more slowly. If this was true, our experimental design might be able to 
identify subjects with deficient descending inhibition that are thus susceptible to 
nocebo effects. Evidence shows that expectations of hyperalgesia blocked the 
analgesic effects of descending inhibition on spinal nociceptive reflexes (RIII-reflex) 
and perceived pain in a DNICS design (Goffaux et al., 2007); however it is possible 
that the mechanisms are different for nocebo induction by conditioning. 
Accordingly, the CS could serve as trigger for the activation of the descending 
control system. 
Whereas one previous study indicated that contingency awareness is a necessary 
condition for placebo-hypoalgesia (Martin-Pichora et al., 2011), the present results 
show that this is not the case for nocebo effects. Similarly, Jensen et al. (2012) 
demonstrated that non-consciously perceived cues can activate nocebo-
hyperalgesia after explicit conditioning, although contingency awareness was not 
assessed. Without contingency awareness explicit expectations cannot develop 
during conditioning, further supporting the notion that conditioning without 
explicit expectations is sufficient to induce a nocebo effect. In general, whether 
awareness is a necessary condition for successful classical conditioning is still a 
question of debate (Clark et al., 2002; Lovibond, 2002). Evidence shows that one 
determining factor might be the design of the conditioning procedure. For 
successful eyeblink conditioning, awareness seems to be required for trace 
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conditioning (i.e., the CS is terminated before the US starts), but awareness does 
not seem to be necessary and rather an epiphenomenon, at most, in delay 
conditioning (i.e., presentation of CS and US overlap and co-terminate; Clark et al., 
2002; Manns et al., 2001; Manns et al., 2002; Perruchet, 1985). As already 
mentioned, the procedure used in this study represents a borderline case in terms 
of delay or trace conditioning. Further, other than in past nocebo studies (Colloca 
& Benedetti, 2006; Colloca et al., 2009; Colloca et al., 2010; Jensen et al., 2012), 
temperature stimuli rather than visual cues were employed as CS. By this means, 
CS and US were both thermal stimuli and processed by overlapping systems. We 
assumed a better comparability to clinical settings due to preparedness (i.e., 
evolutionary advantage; Domjan, 2005; Seligman, 1970) and because it seemed 
more likely that patients are conditioned to interoceptive rather than artificial 
experimental cues (i.e., colored squares or circles), as pain can be viewed as a 
homeostatic emotion, comparable to other homeostatic modalities including 
temperature (Craig, 2003). It is thus conceivable that the choice of stimuli 
promoted implicit conditioning. Accordingly, some subjects developed a subjective 
nocebo effect even though they were not contingency aware and contingency 
awareness was not helpful for the subjective nocebo effect. In a clinical context, 
this means that symptoms can become unconsciously conditioned to (random) 
cues that in turn can, unbeknownst to the patient, trigger these symptoms later. 
This might lead to distrust in therapeutic efficacy, aggravation of illness, and 
unnoticeably contribute to the maintenance of chronic pain (Flor et al., 1990; Flor, 
2000). 
Not surprisingly, a conditioned nocebo effect could not be induced in all subjects. 
Whereas approximately one third of the subjects usually show a placebo response 
in according studies (Beecher, 1955; Hoffman, Harrington, & Fields, 2005), it is not 
known, so far, whether the same responder rate applies to the nocebo effect. In 
the presented study, 71.4 % of the subjects were considered nocebo responders 
when using a criterion that was based on the differential response to both CS in 
the subjective ratings. Applying this criterion resulted in a greater number of 
responders compared to studies in which a median split was conducted to divide 
the sample into “high and low responders” (e.g., Elsenbruch et al., 2012; Scott et 
al., 2007; Scott et al., 2008), but at the same time decreased the effect size of the 
nocebo effect as subjects with small nocebo responses were considered 
responders, too. However, to avoid capitalization of chance (Kriegeskorte et al., 
2009), the described criterion that differentiated between learners and non-
learners was applied only  
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to analyze the behavioral assessment of the nocebo decay. 
Only few studies were concerned with the question whether nocebo responders 
possess specific characteristics (Barsky et al., 2002; Drici, Raybaud, De Lunardo, 
Iacono, & Gustovic, 1995). Other than in a previous study (Colloca et al., 2010), 
state and trait anxiety were not associated with the subjective nocebo effect. The 
nocebo response also did not correlate with pain-related measures of anxiety. Our 
results rather suggest a relation between size of the subjective nocebo response 
and pain sensitivity (i.e., subjective rating of the painful US in the learning phase), 
but not pain threshold and thus physical stimulus intensities. Whether this relation 
between heat-pain sensitivity and nocebo response is mediated by activation of 
the descending inhibitory system remains to be determined.  
In summary, this study indicates that nocebo effects in heat-pain perception can 
be induced by learning alone and that contingency awareness is not necessary. 
Observing the development of the conditioned response over time, its decay was 
apparent in both the subjective and behavioral measure, indicated by increased 
adaption. The nocebo response was not related to anxiety assessed with 
questionnaires but covaried with pain sensitivity, which might be due to 
differences in descending control. The results have important clinical implications 
because they suggest that nocebo effects can be (unnoticeably) learned and cause 
adverse effects. Future studies should investigate whether the mechanisms (e.g., 
decay of the nocebo response in the behavioral measure) are altered in patients 
with chronic pain conditions.  
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2.2 Conditioned Nocebo-Hyperalgesia and Its Relation to 
Autonomic Indices and Personality Traits 
 
Introduction  
The theoretical background for Studies 1 and 2 is largely identical. Study 2 is an 
advancement of Study 1 in methodological and technical terms. Due to the overlap 
in the theoretical background, only changes in Study 2 compared to Study 1 are 
introduced here.  
One aim of this study was to induce nocebo-hyperalgesia, i.e., a nocebo effect 
within the subjectively painful range. In Study 1, non-painful and moderately 
painful stimuli were employed as unconditioned stimuli during learning and only 
the non-painful stimulus was presented during the test phase. Due to the features 
of the VAS, which was dissected in areas describing painful as well as non-painful 
sensations (Lautenbacher et al., 1992), we were able to measure a conditioning-
induced nocebo effect in the non-painful range. In this study, however, we 
increased the stimulus intensities used throughout the experiment and employed 
a mildly painful and a moderately painful stimulus in the learning phase and 
accordingly presented only the mildly painful stimulus during the test phase. 
Further, we based the determination of the presented stimulus temperatures no 
longer on the pain threshold but used a method that depended on the subjective 
perception of the stimuli (Montgomery & Kirsch, 1997; Price et al., 1999; 
Voudouris et al., 1985). It seems more promising to use subjective perception 
instead of a psychophysical entity (i.e., the pain threshold) as a basis for the 
determination of the stimulus intensities for reaching the goal of inducing a 
change in subjective perception.  
A second purpose of this study was to explore effects of the nocebo conditioning 
procedure on the autonomic system. Investigations of psychophysiological 
responses on the nocebo effects are rare, but findings on this regard might 
increase insight into underlying mechanisms of the nocebo effect. For example, 
according to Benedetti (Benedetti, Amanzio, Casadio, Oliaro, & Maggi, 1997; 
Benedetti & Amanzio, 1997; Benedetti et al., 2006; Colloca & Benedetti, 2007) 
nocebo-hyperalgesia is mediated by anxiety-triggered CCK-activation and could be 
blocked with benzodiazepines that abolished HSA-hyperactivity as well as 
hyperalgesia. Accordingly, one study found increased cortisol levels after nocebo 
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suggestions, supporting involvement of stress and anxiety (Johansen et al., 2003). 
Further, another study observed reduced increases in heart rate and sympathetic 
responses during tonic ischemic noxious stimulation after inducing a placebo 
effect by saline versus naloxone injection (the latter reversing the placebo effect 
dependent on opioid systems; Pollo et al., 2003). Atropine injections, however left 
the placebo-hypoalgesia and heart rate responses unaffected, indicating that the 
parasympathetic system was not involved (Pollo et al., 2003). Heart rate measures 
the net effect of autonomic heart control by the sympathetic and parasympathetic 
nervous system in addition to humoral control. Heart rate variability (HRV) on the 
other hand, is a function of cardiorespiratory modulation and indicates 
parasympathetic heart control that is mediated only by the vagus nerve. Measures 
of the time-domain can be employed already for analyzing short periods of time 
(e.g., the duration of one trial as implemented in this study), whereas frequency-
domain measures rely on longer time periods. We hypothesized an increase in 
heart rate and a decrease in HRV after induction of nocebo-hyperalgesia due to 
results indicating reduced parasympathetic activation in response to stress and 
anxiety (Dishman et al., 2000). 
Whereas a number of different personality traits seem to correlate with 
susceptibility for the placebo effect (e.g., hypnotizability/suggestibility: 
Wickramasekera, 1980; De Pascalis, Chiaradia, & Carotenuto, 2002; dispositional 
optimism: Morton, Watson, El-Deredy, & Jones, 2009; reward-related personality 
traits: Schweinhardt, Seminowicz, Jaeger, Duncan, & Bushnell, 2009), not much 
research has investigated personality traits correlating with the nocebo response 
(apart from adverse side effects in drug trials; e.g., Andrykowski & Redd, 1987; 
Uhlenhuth et al., 1998; Geers, Helfer, Kosbab, Weiland, & Landry, 2005; 
Papakostas et al., 2004; Uhlenhuth et al., 1998). So far, only anxiety has been 
shown to correlate with the nocebo effect (Bingel et al., 2011; Colloca et al., 2010). 
However, Study 1 did not reveal a correlation of the nocebo response with state or 
trait anxiety or anxiety measures related to pain, as a number of other studies, too 
(Schmid et al., 2013; Vogtle et al., 2013). Due to the results from placebo research, 
in addition to anxiety, we therefore assessed suggestibility and motivational style 
in the subjects to explore whether a relation of these traits to the nocebo 
response exists. 
Thus, the aim of this study was fourfold: (1) Besides replicating results of Study 1 
(i.e., subjective nocebo response; decay of the nocebo response as indicated in 
subjective and behavioral measures), we strived to (2) induce nocebo-
hyperalgesia, (3) investigate autonomic indices of the nocebo response, and (4) 
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explore the relations of anxiety, suggestibility, and motivational style with the 
nocebo response. 
 
Methods 
The methods employed in Study 2 were identical to Study 1 (please refer to 
section 2.1), except for the following details. 
Subjects  
Twenty-two healthy volunteers (12 females; age: M = 22.6 years, SD = 3.34) 
participated in the study.  
Conditioning procedure 
Every subject performed one session of about 55 minutes duration. A trace 
conditioning design was implemented in this study (please refer to section 
Conditioned stimuli). The test phase of the conditioning task was prolonged in that 
each of the two CS–US combinations was presented in seven instead of five trials 
and further amended by three booster trials, i.e., the presentation of CS+ followed 
by USmoderate pain (cf. section Unconditioned Stimuli). The booster trials were 
implemented in order to enhance the learning effect and prevent extinction. The 
trial order and thereby the sequence of CS+/CS– presentations was randomized 
with the constraint of no more than three subsequent presentations of the same 
CS.  
Unconditioned stimuli  
To determine the intensities of the US, 24 temperature stimuli between 38 and 
48.5 °C were pseudorandomly applied for five seconds each, with an inter-
stimulus-interval of 10 s. One second after the target temperature was reached, 
the subject rated the perceived intensity on a VAS. Individual temperatures 
corresponding to a rating of 50 and 70 were estimated by robust regressions after 
completion of all stimuli and served as USmild pain and USmoderate pain, respectively. In 
contrast to Study 1, we chose this approach (Price et al., 1999) to determine the 
US intensities because we sought to apply an equally painful level of stimulation in 
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subjective perception in all subjects and wanted to warrant that the stimuli were 
in the subjectively painful range. 
Conditioned stimuli 
To increase differentiation of the CS, a short temperature pulse was employed as 
CS rather than the presentation of a constant temperature of five seconds 
duration because dynamically changing stimuli are easier to detect than static 
stimuli (Stančák, Mlynář, Poláček, & Vrána, 2006). Thus, starting at baseline (34 
°C), the temperature changed to 32 °C or accordingly 36 °C and after one second 
shortly returned to baseline before the presentation of the US. 
Heart rate assessment 
To measure heart rate, the subjects wore a POLAR heart rate monitor (RS800) and 
a transmitter with ECG electrodes attached to the chest during the conditioning 
procedure. The equipment recorded the heartbeat peak-to-peak (in ms). Artifacts 
were corrected with the program Polar Pro Trainer. The data was exported to R 
and analyzed with the R package R-HRV (Rodriguez-Linares, Vila, Mendez, Lado, & 
Olivieri, 2008). To reconstruct the time axis, the heart rate was interpolated to 
attain a periodic time frame (4 Hz). After low pass-filtering, average heart rate 
(indicating sympathetic, parasympathetic, and humoral heart control) and HRV 
parameters (indicating parasympathetic heart control) for each trial were 
calculated. Due to equipment failure and errors in data acquisition, physiological 
data of four subjects had to be discarded.  
Questionnaires 
In order to assess motivational style, the behavioral inhibition system and 
behavioral activation system scales (BIS/BAS; Carver & White, 1994; in German: 
Strobel, Beauducel, Debener, & Brocke, 2001) was assessed. Further the subjects 
filled out the Tellegen Absorption Scale (Tellegen & Atkinson, 1974; in German: 
Ritz & Dahme, 1995) measuring absorption, a disposition positively correlated with 
hypnotizability and suggestibility.  
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Results 
Manipulation check 
In the learning phase of the experiment, the subjects clearly distinguished 
between the mildly (M = 29.3, SD = 19.47) and moderately painful US (M = 64.4, SD 
= 25.88) in the subjective ratings (main effect ‘CS’: F(1, 474) = 1080.2, p < .001) and 
sensitized over time (Figure 8A; main effect ‘time’: F(14, 514) = 6.07, p < .001), 
which was more pronounced for moderately painful trials (cued with CS+; 
interaction effect ‘US’ x ‘time’: F(14, 473.9) = 2.76, p = .001).  
Possible confound variables related to the nocebo effect 
In order to investigate possible confounding variables covering a nocebo effect we 
systematically explored a number of potential candidate variables, as in Study 1. 
However, none of the following variables showed a relation to the subjective 
nocebo effect: 
a) sensitization in response to the moderately painful trials during the 
learning phase (please refer to Study 1; main effect ‘sensitization’: F(1, 
122.6) = 5.73, p = .018; interaction effect ‘CS’ x ’sensitization’: F(1, 196.6) = 
.55, p = .457); 
b) distribution of subjective ratings of the painful trials during the learning 
phase (classifying subjects according to their deviation from the Gaussian 
distribution; for more details please refer to Figure SI B in the Appendix; 
main effect ‘deviation’: (F(2, 92.4) = 71.6, p < .001; interaction effect ‘CS’ x 
’deviation’: F(2, 209.4) = 0.05, p = .955); 
c) US temperatures (main effect ‘temperature’: F(1, 110.3) = 5.26, p = .024; 
interaction effect ‘CS’ x ’temperature’: F(1, 177.2) = 1.73, p = .19); 
d) average subjective ratings of moderately painful trials during the learning 
phase (main effect ‘US rating’: F(1, 89.5) = 173, p < .001; interaction effect 
‘CS’ x ’US rating’: F(1, 216.5) = 0.11, p = .737); 
e) difference in the subjective ratings between mildly and moderately painful 
stimulation in the learning phase (main effect ‘VAS difference’: (F(1, 124.9) 
= 11.5, p = .001; interaction effect ‘VAS difference’: F(1, 200.9) = 0.42, p = 
.518); 
f)  average difference in temporal summation or adaption between 
moderately and mildly painful trials (main effect ‘adaption’: (F(1, 120.1) = 
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12.7, p = .001; interaction effect ‘CS’ x ’ ‘adaption’: F(1, 195.4) = 0.29, p = 
.59);  
g) degree of temporal summation or adaption in response to moderately 
painful trials during the learning phase (main effect ‘adaption CS+’: (F(1, 
118.3) = 25.2, p < .001; interaction effect ‘CS’ x ’ ‘adaption CS+’: F(1, 197.7) 
= 0.18, p = .676). 
Subjective nocebo effects  
When comparing the subjective ratings of the mildly painful US cued by the CS+ 
and the CS–, no nocebo effect was observable (main effect ‘CS’: F(1, 195) = 1.14, p 
= .29; Figure 8B), meaning that the subjects did not rate trials cued with CS+ or CS– 
differently. 
Eleven out of 22 subjects (50 %) were successfully conditioned as indicated by 
higher intensity ratings of the temperature when cued by CS+ compared to CS–. 
When the analysis of the nocebo effect was restricted to this learner subgroup, a 
nocebo response could be demonstrated, as expected (main effect ‘CS’: F(1, 95) = 
14.58, p < .001). The learners rated the US as clearly painful (M=52.0, SD=26.2), 
while non-learners perceived the USmild pain as just about painful on average (M = 
40.5, SD = 22.3; T = 5.93, p < .001; Figure 8D).The subjective ratings did not change 
across trials in the test phase (Figure 8C; main effect ‘time’: F(6, 102) = 0.86, p = 
.53) and no interaction effect appeared, indicating that the conditioned effect 
remained stable across the test phase and no extinction occurred (interaction 
effect ‘CS’ x ‘time’: F(6, 95) = 1.88, p = .091). 
Post hoc analyses revealed that the learner group received higher US 
temperatures (USmoderate pain: M = 46.2°C, SD = 1.15; USmild pain: Mlearners = 44.6°C, SD = 
0.95) compared to the non-learners (USmoderate pain: M= 45.2 °C, SD = 1.05; T = 2.22, 
p = .038; effect size: d = 0.91; USmild pain: M = 43.6 °C, SD = 1.05; T = 2.15, p = .044; 
effect size: d = 1). However, the subjective ratings of USmoderate pain and USmild pain 
were not different between learners (USmoderate pain: M = 65.2, SD = 26.01; USmild pain: 
M = 31, SD = 22.38) and non-learners during the learning phase (USmoderate pain: M = 
63.5, SD = 25.75; T = 0.59, n.s.; USmild pain: M = 27.6, SD = 15.85; T = 1.61, n.s.), 
indicating that the stimuli were perceived similar on a subjective level.  
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Figure 8: Subjective ratings (VAS1) throughout the experiment. Depicted are subjective 
ratings (means and standard errors of mean) of trials cued with CS+ (black) and CS– (grey) 
during the learning phase (A) and test phase (B) of the whole sample (N = 22) and during 
the test phase of the learner subgroup (C; N = 11) and non-learner subgroup (D; N = 11). 
The dashed line depicts the pain threshold (VAS = 40). 
 
Subjective decay of the nocebo response 
For an illustration of the subjective ratings after the self-regulation procedure 
(VAS2), please refer to Figure SIII in the Appendix. 
To explore how the subjective rating developed over time within trials, the 
difference between VAS2 and VAS1 was calculated. In the learning phase, the 
difference between the ratings was larger for trials cued with CS+ compared to  
CS–, indicating that the subjects showed temporal summation during the trials in 
response to the moderately painful stimulation (Figure 9A; main effect ‘CS’: F(1, 
512.3) = 45.86, p < .001). The degree of temporal summation decreased over time 
(main effect ‘time’: F(14, 566) = 2.23, p = .006), which was similar for trials cued 
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with either CS (interaction effect ‘CS’ x ‘time’: F(14, 512.3) = 1.41, p = .144). This 
shows that although subjects showed temporal summation during each trial they 
showed habituation across trials, depicting opposing processes on the short- and 
long-term. A subjective decay, as in Study 1, was not apparent. 
In the test phase, the difference in subjective ratings was not different for CS+ and 
CS– when considering the whole sample (main effect ‘CS’: F(1, 206.8) = 0.16, p = 
.694; main effect ‘time’: F(6, 235.2) = 0.82, p = .554; interaction effect ‘CS’ x ‘time’: 
F(6, 206.8) = 1.69, p = .124; Figure 9B) or restricting the analysis to the learner 
subgroup (main effect ‘CS’: F(1, 102.3) = 2.42, p = .123; main effect ‘time’: F(6, 
113.3) = 0.59, p = .737; interaction effect ‘CS’ x ‘time’: F(6, 102.3) = 1.22, p = .302). 
This means that a subjective decay of the nocebo response, as shown in Study 1, 
could not be demonstrated. 
 
 
Figure 9: Subjective decay of the conditioned nocebo response (VAS2 – VAS1) throughout 
the experiment. Depicted are the differences in subjective ratings (means and standard 
errors of mean) of trials cued with CS+ (black) and CS– (grey) during the learning phase (A) 
and test phase (B) of the whole sample (N = 22).  
 
Self-regulation procedure 
Corresponding to the subjective ratings, no nocebo effect in the behavioral 
response emerged in the test phase, considering the whole sample (main effect 
‘CS’: F(1, 248.3) = 0.72, p = .397; main effect ‘time’: F(6, 288.3) = 0.45, p = .844; 
interaction effect ‘CS’ x ‘time’: F(6, 248.3) = 0.94, p = .464; Figure 10B). Contrary to 
our hypothesis, however, restricting the analysis to the learner subgroup, no 
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conditioned effect occurred (main effect ‘CS’: F(1, 129.9) = 0.18, p = .668; main 
effect ‘time’: F(6, 151) = 0.48, p = .822; interaction effect ‘CS’ x ‘time’: F(6, 129.9) = 
1.4, p = .218). These results indicate that a decay of the conditioned nocebo 
response in the behavioral measure could not be shown. 
In the learning phase of the experiment, increased temporal summation for 
moderately painful compared to mildly painful trials was observable in the 
behavioral response (Figure 10A; main effect ‘CS’: F(1, 502.6) = 36, p < .001). The 
degree of temporal summation decreased over time (Figure 10A; main effect 
‘time’: F(14, 574) = 2.34, p = .004) but this was similar for both trials cued with CS+ 
and CS– (interaction effect ‘CS’ x ‘time’: F(14, 502.6) = 0.9, p = .556). 
 
 
Figure 10: Behavioral responses throughout the experiment. Illustrated are the self-
adjusted temperature changes (means and standard errors of mean) of the single trials 
cued with CS+ (black) and CS– (grey) during the learning phase (A) and the test phase (B; N 
= 22). 
 
Autonomic indicators: heart rate and parasympathetic heart control  
The mean trial length on which heart rate and heart rate variability are based was 
1:13:24 min. (SD = 11.46 sec). 
Trials cued by CS+ or CS– did not show differences in heart rate in the learning 
phase (CS+: M = 76.4, SD = 9.07; CS–: 76.1 SD = 9.02) or the test phase (CS+: M = 
75.1 SD=9.05; CS–: M = 75.3 SD = 9.19). In the test phase, no significant differences 
between trials cued with CS+ (M = -0.13, SD = 1.32) and CS– (M = -0.28, SD = 1.14) 
emerged, neither within the whole sample nor within a subgroup. 
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Post hoc analyses, however, showed that the learners and non-learners differed in 
their autonomic responses during the learning and test phase. The learner 
subgroup had increased heart rate compared to the non-learners and reduced 
HRV in almost all reported parameters (Table 1), indicating reduced 
parasympathetic activity in both the learning and the test phase. 
 
Table 1: Heart rate and heart rate variability parameters for learners (N = 8) and non-
learners (N = 10). 
 learning phase test phase 
parameter learners non-
learners 
t-test learners non-
learners 
t-test 
 M, SD M, SD T, p M, SD M, SD T, p 
HFREQ 78       
8.11 
74.9           
9.51 
4.1               
<.001 
77.7       
8.03 
73.2          
9.41 
4.4      
<.001 
nNN50 12.4   
10.79 
14       
10.96 
-1.8         
.081 
11.9     
10.13 
15.1    
11.59 
-.25      
.011 
pNN50 17.5  
15.57 
20.4    
17.34 
-2            
.045 
17        
14.91 
22.7     
18.97 
-2.9      
.003 
RMSsd 35.1   
17.64 
39.9     
16.38 
-3 3         
.001 
35.3     
17.56 
43.5     
19.25 
-3.9     
<.001 
RRms 782.1  
85.6 
819.7 
113.16 
-4.4               
< .001 
785.8  
86.63 
839.4 
114.61 
-4.7            
< .001 
M, mean; SD, standard deviation; T, T-value, p, p-value; HFREQ, heart rate frequency; 
nNN50, proportion of the number of pairs of successive beat-to-beat intervals that differ 
by more than 50 ms divided by total number of beat-to-beat intervals; pNN50, percentage 
of differences of subsequent beat to beat intervals greater than 50 ms; RMSsd, root mean 
square of successive differences; RRms, time of beat-to-beat interval in ms. 
 
Contingency awareness  
All subjects were able to distinguish the two CS (32°C and 36°C pulse), as verified 
prior to the conditioning task. Seven subjects out of 21 (33.3 %) were able to 
describe the contingency between the CS and the US in the interview after the 
experiment and three out of these seven (42.9 %) belonged to the learner 
subgroup. Of the fourteen subjects who did not become contingency aware, eight 
(57.1 %) belonged to the learner subgroup, indicating that contingency awareness 
was not a necessary condition for successful conditioning of the subjective nocebo 
response. The positive intercept in the regression analyses (intercept = 1.3) 
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confirmed that the nocebo response was independent of contingency awareness, 
as expected (Figure 11). Further, the negative slope (slope = -0.6) revealed that 
contingency awareness was not helpful for the nocebo effect.  
 
Figure 11: Regression of subjective nocebo effect with contingency awareness. 
Participants were categorized as aware or unaware of the contingency between CS and US. 
The notch of the box plots displays the median and the length of the notched bar displays a 
confidence interval around the median. 
 
Anxiety, motivational style, and suggestibility 
A negative correlation of trait anxiety with the subjective nocebo response 
(r = -0.466, p = .033) emerged, after exclusion of an outlier from the analysis 
(Figure 12). Contrary to our hypothesis, learners were habitually less anxious 
(M = 32, SD = 3.5, N = 10) compared to non-learners (M = 37.4, SD = 7.28, N = 11). 
No correlations of the nocebo response with state anxiety (r = -0.076, p = .738), BIS 
score (r = -0.45, p = .843), sum score or subscales of BAS (all p > .104), or 
suggestibility measures (r = -0.099, p = .66) were detectable and no differences 
between learners and non-learners appeared. 
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Figure 12: Negative correlation of trait anxiety and the subjective nocebo response 
(r = -0.466, p = .033, N = 21). 
 
Discussion 
Nocebo conditioning led to a subjective nocebo response within the painful range 
(i.e., nocebo-hyperalgesia), however, only in part of the sample, in line with 
previous studies. These learners were presented with significantly higher stimulus 
intensities and evaluated the stimuli as more painful during the test phase, but not 
during the learning phase of the experiment. They further had an increased heart 
rate and reduced HRV parameters, compared to the non-learners. Contingency 
awareness was independent from and proved to be not helpful for the learning of 
the subjective nocebo response. A decay of the conditioned response over time 
could not be demonstrated within the subjective or behavioral measures, in 
contrast to Study 1. Successfully conditioned subjects had lower scores on trait 
anxiety and the less anxious subjects were the greater was the subjective nocebo 
response. Motivational style and suggestibility were not correlated with the 
subjective nocebo response.  
By partially replicating results from Study 1, we could demonstrate that classical 
conditioning without conscious expectation is sufficient to induce a nocebo 
response. A number of possible confounding variables was explored, but a 
covariation with the nocebo response was not found. In contrast to Study 1, 
subjective ratings in the test phase of this experiment were above the pain 
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threshold, indicating nocebo-hyperalgesia. Further, significantly different stimulus 
intensities albeit equivalent subjective ratings (as ensured by the determination of 
US intensities and comparison of the subjective ratings during the learning phase) 
were applied in the learner and non-learner subgroup. However a lack of 
difference in the subjective ratings does not mean that stimuli of different 
temperatures are equivalent at the neurophysiological, neural or behavioral level. 
This finding suggests that nocebo-hyperalgesia might be more readily induced with 
higher stimulus intensities. 
Most subjects remained contingency unaware throughout the experiment despite 
increased differentiation of the stimuli compared to Study 1. The proportion of 
subjects who recognized the contingency was even lower than in Study 1, which 
might be due to greater distraction by the increased painfulness of the stimuli or 
the employed conditioning design, which was a trace conditioning in this case. 
However, replicating results from Study 1, contingency awareness neither was 
necessary for the subjective nocebo effect to occur nor was it beneficial, showing 
again that a nocebo response can be learned without explicit expectations. 
Contrary to results in the context of the placebo effect (Wickramasekera, 1980; De 
Pascalis et al., 2002; Schweinhardt et al., 2009), suggestibility and motivational 
style did not correlate with the nocebo effect in this study, further emphasizing 
that the nocebo effect is not just a reversed placebo effect (Benedetti et al., 2006; 
Colloca et al., 2008; Kong et al., 2008). Trait anxiety strongly correlated with the 
nocebo effect in this study, however, contrary to our hypothesis, the more 
habitually anxious the subjects were the smaller the nocebo effect appeared. A 
similar result was reported by Colloca et al. (2010) who found a negative 
correlation of the nocebo response with trait (and state) anxiety after a short 
conditioning procedure with non-painful stimuli and a positive correlation after 
conditioning with painful stimuli. Compared to Colloca's et al. (2010) study, our 
procedure was of medium length (15 trials compared to 5 trials in the short and 20 
trials in the long conditioning procedure). Although in Study 1, the employed 
stimuli were non-painful, we did not observe a relation between anxiety and the 
subjective nocebo response. Further, the learners, who showed less anxiety than 
the non-learners, rated the presented stimuli as above the pain threshold and 
reported significantly more pain than the non-learners. Although the learners 
received higher stimulus intensities, trait anxiety did not correlate with stimulus 
intensity (r = -0.308, p = .175), indicating that the negative correlation between 
anxiety and the nocebo effect cannot be attributed to differences in stimulus 
intensity. Other studies that employed painful stimulation did not find correlations 
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with anxiety (Schmid et al., 2013; Vogtle et al., 2013). These unexplained 
differences in the role of anxiety might partly be due to variations in experimental 
designs. Unquestioned, knowledge on characteristics of nocebo responders is 
important because it can be utilized in the clinical context. For example, subjects 
that are identified as being highly susceptible for nocebo effects could be 
administered a special treatment (e.g., additional information) in order to prevent 
the development of nocebo-related adverse effects. For this reason the relations 
between the nocebo response and anxiety besides other potential personality 
traits or characteristics should be further explored. 
As autonomic measures, we investigated heart rate and time domain parameters 
of HRV because the trial length was too short to explore parameters from the 
frequency domain. Changes in HRV can reflect reactivity of the autonomic system 
in response to environmental and experimental conditions (Berntson et al., 1997; 
Porges, 2007) and especially pain (Koenig, Jarczok, Ellis, Hillecke, & Thayer, 2013; 
Loggia, Juneau, & Bushnell, 2011). Accordingly, placebo-hypoalgesia has shown to 
be accompanied by reduced heart rate and increased sympathetic components 
(Aslaksen & Flaten, 2008; Pollo et al., 2003). As muscarine blockade left the 
placebo-hypoalgesia unaffected the authors concluded that parasympathetic 
systems were not involved (Aslaksen & Flaten, 2008; Pollo et al., 2003). Although 
in the present study, a nocebo effect in the autonomic measures on single trial 
level (i.e., difference between trials cued by CS+ and CS–) was not detected, 
autonomic indices were different between learners and non-learners. Evidence 
shows that heart rate responses are more closely related to subjective sensation 
than to stimulus intensities (Möltner, Hölzl, & Strian, 1990), which is in line with 
the observation in this study that learners evaluated the presented stimuli as more 
painful during the test phase of the experiment. The fact that learners displayed a 
pattern of increased heart rate and decreased HRV already in the learning phase, 
suggesting decreased parasympathetic activation, might indicate that the learner 
were more stressed by the pain stimulation compared to the non-learners and as a 
consequence learned more successfully, as evidence shows that stress can 
enhance conditioning (Duncko, Cornwell, Cui, Merikangas, & Grillon, 2007; Shors, 
Weiss, & Thompson, 1992).  
In contrast to Study 1, the learner subgroup did not display a decay of the nocebo 
response in the subjective and behavioral measures. This might be due to different 
aspects which differentiate this study from the previous one. For example, the 
temperatures employed in this study were higher, which might have promoted 
effects of temporal summation and perceptual sensitization, interfering with the 
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decay of the conditioned response. It could be the case that it takes longer for the 
pain system to “recover” with stronger pain stimulation. Another possibility is that 
the conditioning was not strong enough (as indicated by the lower number of 
successfully conditioned subjects compared to Study 1). Assuming that effects of 
descending inhibition might play a role in the pattern observed in the behavioral 
and subjective measures of decay of the conditioned response and that 
descending inhibition might be triggered by the CS, it could be concluded that 
weaker conditioning leads to less descending inhibition, preventing the occurrence 
of decay indicated by adaption. 
The newly introduced booster trials (presenting CS+ followed by the moderately 
painful stimulus three times across the test phase) might provide an explanation 
for the generally less pronounced conditioning success compared to Study 1. They 
had the purpose to increase the conditioned nocebo effect and prevent quick 
extinction. However, according to the theory of adaptation-level (Helson, 1947), a 
stimulus far above the stimulus range (i.e., during a booster trial) will change the 
adaption level. As a consequence, the discrimination of stimuli at previous 
stimulus range (i.e., the mildly painful intensity cued with CS+ or CS– during the 
test phase) deteriorates. Thus, the booster trials might have diminished the 
conditioning effect. In addition to that, one can assume that effects of distraction 
are stronger the more painful the employed stimuli are. Consequently, with the 
increased intensity level compared to Study 1, successful conditioning might have 
been more difficult to achieve. 
In conclusion, the present study shows that subjective nocebo-hyperalgesia was 
successfully conditioned in part of the sample. Learners compared to non-learners 
were lower in trait anxiety, developed increased heart rate and decreased HRV, 
and subjectively rated the stimuli as more painful during the test phase. 
Contingency awareness was independent from learning and neither motivational 
style nor suggestibility were correlated with the nocebo response. Presumably due 
to several modifications compared to Study 1 (e.g., booster trials, trace 
conditioning, higher stimulus intensities) the conditioning effect was less 
pronounced and a decay of the conditioned response over time could not be 
shown in the subjective and behavioral measures.   
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3. Neural Correlates of Pain Sensitization Induced by 
Uncontrollability  
 
Introduction 
Would you rather remove a splinter from your finger yourself or let somebody else 
do it? Many people would choose the former, illustrating the empowerment of 
having control over pain (Bowers, 1968). Conversely, not having control over pain 
is particularly relevant from a clinical point of view: it leads to feelings of 
helplessness (Burger, 1980; Maier & Watkins, 2005) and contributes to chronic 
pain and co-morbid depression (Flor et al., 1990; Müller, 2011). For improving pain 
management and therapy, a better understanding of pain uncontrollability is 
deemed essential (Borckardt et al., 2011; Haythornthwaite et al., 1998). 
Experimental work confirms that controllable pain stimuli are perceived as less 
intense than uncontrollable stimuli (Arntz & Schmidt, 1989; Müller, 2011). Human 
as well as animal studies point to an important role of the prefrontal cortex in 
mediating analgesic effects of (perceived) control over pain (Amat et al., 2005; 
Borckardt et al., 2011; Wiech et al., 2006). In contrast, it is currently unknown 
which brain areas drive the augmentation of pain when the stimulus is 
uncontrollable. 
Candidate brain regions should show increased activation when pain is 
uncontrollable compared to when it is controllable. Several brain regions 
associated with pain processing, including ACC, insula, SI, SII, amygdala, PAG, and 
PFC (Helmchen et al., 2006; Mohr et al., 2005; Salomons et al., 2004; Salomons et 
al., 2007; Wiech et al., 2006) have been identified to fulfill this criterion. However, 
activation in many of these regions scales linearly with perceived pain intensity 
(Coghill, Sang, Maisog, & Iadarola, 1999; Loggia et al., 2012; Seminowicz & Davis, 
2007), and signal increases in such areas might therefore reflect the increased pain 
perception when pain is uncontrollable. But three regions, namely PAG, amygdala, 
and perigenual ACC (pACC), that have been reported to show increased activation 
when pain is uncontrollable, are interesting candidates because their stimulus-
response curves do not typically follow a simple linear relationship (Bornhovd et 
al., 2002; Loggia et al., 2012; Neugebauer & Li, 2002; Porro, Cettolo, Francescato, 
& Baraldi, 1998). Furthermore, PAG, amygdala, and pACC are known to play 
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important roles for endogenous pain modulation (Bingel, Lorenz, Schoell, Weiller, 
& Büchel, 2006; Neugebauer, Li, Bird, & Han, 2004; Vanegas & Schaible, 2004). The 
PAG is a major relay site of the descending pain modulatory system and involved in 
pain facilitation (Gwilym et al., 2009; Porreca et al., 2002; Yoshida et al., 2013). The 
amygdala plays a key role in fear and threat processing, also in the context of pain 
(Neugebauer et al., 2004; Phelps & LeDoux, 2005), and it has been hypothesized 
that a lack of control increases the threatening value of pain (Arntz & Schmidt, 
1989; Bowers, 1968). Lastly, the pACC is involved in different types of cognitive-
emotional modulation of pain (Bingel et al., 2006; Wiech, Ploner, & Tracey, 2008) 
and has been shown to exhibit heightened activation when pain is provoked in 
sensitized states (Lorenz et al., 2002).     
Here, we tested the hypothesis that a circuitry encompassing PAG, amygdala, and 
pACC mediates pain augmentation by uncontrollability, using fMRI. An 
experimental design allowing the dynamic investigation of pain processing and 
sensitization was used to differentiate between brain areas reflecting increased 
pain processing and a network of brain structures driving the increased pain 
perception. 
 
Methods 
Subjects 
Inclusion criteria included age between 18 and 40 years and good health. Exclusion 
criteria comprised the presence of any chronic pain condition, presence or history 
of significant neurological or psychiatric disease; presence of any significant 
medical condition; regular consumption of alcohol or recreational drugs; recent 
use of any pain medication; regular or frequent night shift work, presence of any 
sleep disorders. The study was approved by the local ethics committee, and 
written informed consent was obtained from all subjects. Subjects were 
compensated for their participation. 
Three subjects were excluded because the painful stimulus was not evaluated as 
painful during more than 50 % of the pain trials. The final sample consisted of 23 
volunteers (13 males; 1 left-handed), aged 19–30 years (mean 24.2 ± 3.57 years). 
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General procedure 
Each subject underwent two sessions: a familiarization session and an fMRI 
session, spaced by one to three days.  
Familiarization session 
The study was explained to the subject and after obtaining informed consent, 
subjects were familiarized with the stimuli, the tasks, and the rating scales and 
their pain thresholds were assessed. Cutaneous heat stimuli were delivered using a 
30 x 30 mm contact thermode (Pathway, Medoc Ltd Advanced Medical System, 
Israel). Stimulus intensities were individually determined (see below); but 
temperatures above 50 °C were not allowed for safety reasons. A vertically 
oriented visual analog scale (VAS) anchored with 0 (no sensation), 40 (just painful, 
defined as the pain threshold), and 100 (most intense pain tolerable) was used to 
rate non-painful and painful sensations. This VAS has been shown to possess linear 
properties (Lautenbacher et al., 1992). Pain tolerance testing was performed so 
that the subjects experienced a sensation that corresponded to the upper end of 
the VAS, thereby providing a perceptual anchor. For this, the thermode was 
applied to the subject’s forearm and the temperature slowly increased (rise rate 
0.5 °C/s) from 32 °C until the subject stopped it by pressing a button on the 
response unit. This procedure was repeated twice with a rise rate of 1.5 °C/s. 
To assess the pain threshold, a series of stimuli was applied to the testing site to 
be used during the fMRI, i.e., the subject’s non-dominant thenar eminence. After 
each stimulus, the subject indicated the most intense sensation on the VAS. The 
baseline temperature was 36 °C and the first target temperature was 39 °C (rise 
rate of 2.5 °C/s, stimulus duration 5 s). The subsequent target temperatures each 
increased by 1 °C until the subject rated a stimulus as ‘just painful‘. Subsequently, 
five more temperatures around this initial painful temperature were applied to 
determine the pain threshold. The resulting average pain threshold was 44.2 °C 
(SD = 1.42 °C), consistent with the literature (Rolke et al., 2006).  
The temperature to be used as initial temperature in the controllable pain trials 
was based on the individual’s pain threshold by adding 1.5 °C; however, 
adjustments were made if this temperature was not rated as moderately painful or 
did not fall between 45.5 °C and 48°C (mean temperature = 47 °C, SD = 0.78 °C). 
For the controllable warm trials, the initial temperature was 39 °C or 40 °C, 
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depending on the subject’s rating in the familiarization session (mean temperature 
= 39.5 °C, SD = 0.5 °C). 
Experimental design 
The study followed a within-subject yoked-control design with two within factors 
(condition ‘controllable’ vs. ‘uncontrollable’ and stimulation intensity ‘moderate 
pain’ vs. ‘warmth’). The sequence of stimulation intensities was pseudo-
randomized with the same order across subjects. In each functional scan, the first 
12 trials were controllable, followed by 12 uncontrollable trials to avoid frequent 
switching between the two conditions so that subjects would not be confused with 
respect to the task to be performed in a specific trial. In the controllable condition, 
subjects performed a temperature regulation task (Becker et al., 2011; Hölzl et al., 
2005; Kleinböhl et al., 1999). After the thermode had reached the target 
temperature, the subject had to keep his/her sensation of the stimulus constant by 
antagonizing any perceived temperature change with the response unit by 
regulating the temperature down or up using the left or right mouse button, 
respectively. If the sensation had not changed, subjects had to press the middle 
mouse button to control for motor responses. Because the temperature only 
changed when the subject regulated it, any change perceived by the subject was 
due to temporal summation or adaption. A flashing arrow reflected the subject’s 
response and served as visual feedback to minimize unspecific differences to the 
uncontrollable condition. After 20 s the temperature returned to baseline. In the 
uncontrollable condition, the temperature profiles of the previous controllable 
trials were replayed (yoked control). The subject had to continuously rate the 
sensation on the VAS, which was projected onto the screen. If the sensation had 
not changed, subjects had to press the middle mouse button. During both tasks a 
green square flashed every two seconds prompting the subject to give a response, 
controlling for response rate. The inter-trial-interval was 20 s.  
Questionnaires 
The IPC scale (Levenson, 1981) was used to identify the locus of control beliefs 
(subscales: internal, powerful others, and chance). Twenty subjects completed this 
questionnaire. All subjects completed the State-Trait Anxiety Inventory (STAI; 
Spielberger, 1970) indicating their level of state and trait anxiety.  
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FMRI session 
At the beginning of the fMRI session, subjects were reminded of the tasks and 
stimulus intensities were adjusted if necessary. FMRI data acquisition was 
performed in two functional scans, separated by an anatomical scan.  
Stimulus presentation was controlled by a personal computer using Eprime 
software (Psychology Software Tools Inc., Pittsburgh, USA). The display was back-
projected onto a screen, visible via a mirror that was mounted on the head-coil of 
the MRI scanner. A computer mouse with three buttons was modified in-house to 
ensure MR-compatibility and allow for communication with the software. The 
mouse served as response unit so that the subjects could perform the 
experimental tasks.  
FMRI data acquisition 
Imaging data were acquired on a 3 T Siemens TRIO MRI scanner at the McConnell 
Brain Imaging Center, Montreal Neurological Institute (MNI). A multi-slice, 
gradient-echo EPI sequence covering the whole brain was used for functional 
scans (TR = 2.62 s, TE = 30 ms, flip angle = 90 degree, 44 interleaved, 3.5-mm thick 
axial slices (parallel to the AC-PC line), field of view (FoV) 224 mm x 224 mm, 
matrix 64 x 64, resulting in an in-plane resolution of 3.5 x 3.5 mm2, 441 image 
volumes). The first two images were discarded to allow steady state 
magnetization. Field maps were obtained using a gradient echo sequence (TE = 20 
ms, 0.47 ms dwell time, FoV and matrix identical to EPI). High-resolution, 
anatomical T1-weighted images (RF spoiled, pre-scan normalized MPRAGE 
sequence, TR = 2300 ms, TE = 2.98 ms, TI = 900 ms, flip angle = 9 degree, FoV 192 
mm x 256 mm x 256 mm, matrix 192 x 256 x 256, hence voxel size: 1 mm3) were 
acquired for all subjects for co-registration purposes. 
Statistical analysis of behavioral data 
Mean values and standard deviations were calculated for the self-adjusted 
temperature changes and the subjective ratings of the intensity. Two-sided t-tests 
were used to investigate whether the temperatures, respectively VAS ratings, at 
the end of the trial differed from the value at the beginning of the trial. A linear 
mixed model was used to test whether the VAS ratings changed over subsequent 
trials. The IPC scores were correlated with the psychophysical data using Pearson’s 
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correlations. Alpha = 0.05 was used as significance level. Statistical tests were 
performed with PASW Statistics 17.0.3. Figures were prepared with R 2.11.1. 
Statistical analysis of fMRI data 
All image processing and statistical analysis was performed using the software 
package FSL 4.18 (FMRIB's Software Library; http://www.fmrib.ox.ac.uk/fsl; Smith 
et al., 2004). Out of 1104 trials in total, 19 trials were excluded due to missing data 
caused by technical problems, such as thermode malfunction. Eleven trials were 
shortened due to deviations from the specified temperature profile. 
Subject level analysis. The following preprocessing steps were applied to each 
functional dataset: denoising using MELODIC (Multivariate Exploratory Linear 
Optimized Decomposition into Independent Components) within FEAT (FMRI 
Expert Analysis Tool), spatial smoothing (Gaussian kernel, full width at half-
maximum: 5 mm), motion correction, and temporal highpass filtering (Gaussian-
weighted least-squares straight line fitting with sigma = 100 s). Susceptibility-
related distortions were corrected using FSL field map correction routines. 
A general linear model (GLM) was applied to each functional dataset, modeling the 
four conditions (controllable-painful, controllable-nonpainful, uncontrollable-
painful, uncontrollable-nonpainful). In a second GLM, total temperature changes 
over the course of individual controllable trials (excluding the stimulus rise time), 
moment-to-moment temperature changes reflecting temperature changes every 
second (controllable trials), intensity ratings over the course of individual 
uncontrollable trials, and moment-to-moment changes of intensity ratings 
(uncontrollable trials) were included as explanatory variables in addition to the 
four explanatory variables for condition. To account for the time subjects needed 
to ‘catch up’ with the initial temperature increase of the thermode in the 
uncontrollable condition, the first 4 seconds of the 20 second stimulation period 
were not included in the regressors (please refer to Figure 13). This model allowed 
identifying a) brain activation correlating with sensitization in the respective 
conditions, and b) activation that is neither explained by condition nor by increases 
in pain perception and should thereby reveal brain regions that drive the 
sensitization (DRIVE contrast). Regressors were convolved with a gamma 
hemodynamic response function and the first temporal derivatives were included. 
Multicollinearity between the regressors was ruled out by correlation analyses. 
Temperature rise and fall times, motion outliers, and time series for cerebrospinal 
fluid and white matter were included in the models as nuisance variables. Voxel-
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wise parameter estimates (PEs) were derived using the appropriate contrasts. 
Individual’s functional images were registered to the 152 template in MNI 
standard space using linear (FLIRT, Jenkinson, Bannister, Brady, & Smith, 2002) and 
non-linear transformations (FNIRT, warp resolution=10 mm). These transforms 
were applied to the subject-level statistical images. 
Group level analysis. The parameter estimates and the corresponding estimates of 
the variance from the two functional scans of each subject were merged in a 
second level fixed effects analysis. Third level analyses were performed using a 
mixed-effects model, implemented in FLAME (Beckmann, Jenkinson, & Smith, 
2003). Statistical inference was based on the whole brain with a voxel-based, 
cluster-forming threshold of Z = 2.3 and correction for spatial extent according to 
Gaussian random field theory (Worsley, Evansy, Marretty, & Neeliny, 1992) at a 
cluster-level of p < 0.05. For the second GLM, constructed to identify areas that 
drive uncontrollability-induced pain increases, we employed additional region of 
interest (ROI) analyses, in particular because the hypothesized regions (PAG, 
amygdala, pACC) are small. ROIs of the brainstem, bilateral amygdala, and pACC 
were defined anatomically on the MNI-152 template by means of the Harvard-
Oxford Cortical and Subcortical Atlases as implemented in fslview 4.18 and 
transformed in each individual’s functional space. A voxel-based threshold of Z = 
1.6, cluster-level corrected at p < 0.05 was used for statistical inference of ROI 
analyses.   
Localization of activation was achieved by inspection of group activation maps 
overlaid onto the average high-resolution image of the subjects. Coordinates are 
given in MNI space. 
 
Results 
Behavior 
In the controllable condition during painful trials, subjects regulated the 
temperature down in order to keep their sensation constant (Figure 13A), which 
indicated that temporal summation occurred over the course of the 20 second-
long trials (temperature difference between end and beginning of the trial: M = -
0.7 °C, SD = 0.398 °C; T = 8.41, p < 0.001). During warm trials, subjects on average 
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increased the temperature, i.e., they adapted to the stimulus (M = 0.19 °C, SD = 
0.305 °C; T = -3, p = 0.007, Figure 13B). 
 
Figure 13: Psychophysical data of painful (A) and non-painful trials (B). Illustrated are the 
temperature courses in blue, averaged across trials and particpants, and the Visual Analog 
Scale (VAS) ratings, equally averaged across trials and particpants, in red. For better 
illustration, we downsampled the displayed data (interval length = 250 ms). Grey ribbons 
represent the standard error of the mean. Because increasing ratings at the beginning of 
the uncontrollable trials do not reflect increasing pain sensation (the subjects needed time 
to adjust their rating after the thermode had reached the target temperature), the first 4 
seconds of the uncontrollable trials were excluded. The red bars indicate the time segment 
that was included in the comparison of intensity ratings between end and beginning of the 
trial as well as as pain rating regressors in the fMRI analysis of the uncontrollable trials (see 
Methods). The red dotted line depicts the “just painful” anchor of the VAS. The blue dotted 
line markes adaption (values > 0) and temporal summation (values < 0) for the controllable 
trials. The initial variations in temperature were due to fluctuations of the thermode. 
 
In the uncontrollable condition, subjects were administered the identical 
nociceptive input as in the controllable condition by replaying the self-adjusted 
temperature time courses of the controllable trials. In line with the notion that 
uncontrollability increases pain, they rated the sensation as continuously getting 
more painful during pain trials (rating difference between end and beginning of 
trial: M = 23.2, SD = 9.22; T = 10.95, p < 0.001; Figure 13A), despite that they had 
regulated the temperature time courses to produce constant sensations in the 
controllable condition. During warm trials, the ratings remained stable throughout 
the trial (M = 0.38, SD = 1.06; T = 0.51, p = 0.62; Figure 13B) and thus matched the 
perceived sensation in the controllable condition. These results indicate that the 
effects of uncontrollability on the perception of thermal stimuli are specific for 
painful sensations.   
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The design required that the uncontrollable trials were presented after the 
controllable trials. But sensitization across trials can be ruled out as an alternative 
explanation for the increased pain in the uncontrollable trials because pain ratings 
did not increase across trials (please refer to Figure SIV in the Appendix; 
interaction effect ‘Trial’ x ‘Intensity’: F(5, 514) = 0.7, p = 0.626).  
Locus of control and anxiety scores 
Regarding individual control beliefs, the extent of temperature change in the 
controllable painful condition correlated positively with the “powerful others 
subscale” of the IPC locus of control scale (r = 0.59, p = 0.012). This indicates that 
the more a subject believed that his/her life is controlled by others, the more 
he/she showed temporal summation. Neither trait (M = 36.4, SD = 9.74) nor state 
anxiety scores (M = 29.1, SD = 8.07) correlated with the behaviorally indicated 
change in sensation in the controllable or uncontrollable conditions (all p-values > 
0.46). 
 
 
Figure 14: Brain responses to painful vs. warm stimulation, irrespective of the task 
(controllable and uncontrollable painful > controllable and uncontrollable warm). 
Increased activation in pain processing brain areas: bilateral insula (ins), thalamus (tha), 
basal ganglia (bg), secondary somatosensory cortex (SII), premotor cortex (PMC), and 
anterior cingulate cortex (ACC). Statistical inference was based on a voxel-based threshold 
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of Z = 2.3 and a cluster-based threshold of p = 0.05, corrected for multiple comparisons 
across the whole brain. The activation map is overlaid on the MNI-152 template. Images 
are displayed in radiological convention, i.e., right side of the brain is on the left. For details 
see Supplementary Table I 
 
Figure 15: Brain responses to uncontrollable painful stimulation compared to 
controllable painful stimulation (uncontrollable painful > controllable painful). Increased 
activation was detected in periaqueductal gray (PAG) and bilateral thalamus (tha). 
Statistical inference was based on a voxel-based threshold of Z = 2.3 and a cluster-based 
threshold of p = 0.05, corrected for multiple comparisons across the whole brain. The 
activation map is overlaid on the MNI-152 template. Images are displayed in radiological 
convention, i.e., right side of the brain is on the left. For details see Supplementary Table II. 
 
 
Figure 16: Brain activation correlating with temporal summation in the controllable 
condition. Remarkably, no activation in pain processing areas correlated with temporal 
summation in the controllable condition. Statistical inference was based on a voxel-based 
threshold of Z = 2.3 and a cluster-based threshold of p = 0.05, corrected for multiple 
comparisons across the whole brain. The activation map is overlaid on the MNI-152 
template. Images are displayed in radiological convention, i.e., right side of the brain is on 
the left. For details see Table S4. pHC, parahippocampus; SI, primary somatosensory 
cortex; PCu, precuneus; FEF, frontal eye field. For details see Supplementary Table III. 
 
Brain activation in response to painful stimulation 
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When pain trials were compared to warm trials, activations were found in typical 
pain processing areas including bilaterally insula, ACC, SII, premotor cortex, basal 
ganglia and thalamus (Figure 14, Supplementary Table I). Activations for the 
controllable and uncontrollable condition were largely similar albeit PAG activation 
was only found for the uncontrollable condition, and was significant in the contrast 
Painuncontrollable minus Paincontrollable. Similarly, thalamic activation was significantly 
stronger during uncontrollable pain than during controllable pain, mainly in the 
right hemisphere (Figure 15, Supplementary Table II). 
 
 
Figure 17: The subjective ratings of the uncontrollable painful condition correlated with 
activation in pain processing areas: insula, basal ganglia (bg), thalamus (tha), anterior 
cingulate cortex (ACC), premotor cortex (PMC). This activation is controlled for activation 
unrelated to subjective perception (constant regressor) and activation that might be 
driving the increases in pain perception (moment-to-moment changes of pain perception). 
Statistical inference was based on a voxel-based threshold of Z = 2.3 and a cluster-based 
threshold of p = 0.05, corrected for multiple comparisons across the whole brain. The 
activation map is overlaid on the non-linear Montreal Neurological Institute (MNI)-152 
template. Images are displayed in radiological convention, i.e., right side of the brain is on 
the left. For details see Supplementary Table IV. 
 
Brain activation associated with temporal summation in the controllable condition 
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Activation in none of the pain-processing regions correlated with the down-
regulation of the temperature, indexing temporal summation, in the controllable 
pain trials. Areas in which activation correlated with the temperature time course 
included the precuneus, the parahippocampus, and an area in vicinity to the 
frontal eye field (Figure 16, Supplementary Table III), which is interesting because 
it might reflect the cognitive and attentional demand of the task. 
Brain activation associated with the additional sensitization in the uncontrollable 
condition 
The increases in pain perception in the uncontrollable condition, indexed by 
subjective ratings, correlated with activation in typical pain processing regions, 
including bilateral insula, rostral and mid ACC, supplementary motor cortex (BA8), 
bilateral anterior and medial thalamus, lateral thalamus mainly contralateral to 
stimulation site, lentiform nucleus, and occipital lobe (Figure 17, Supplementary 
Table IV). 
 
 
Figure 18: Activation in perigenual anterior cingulate cortex (pACC; x = 2, y = -36, z = -16, Z 
score peak = 2.88, cluster size = 12 voxels) and periaqueductal gray (PAG; x = -2, y = 30, z = 
-2, Z score peak = 3.3, cluster size = 2 voxels) correlated with moment-to-moment changes 
in pain perception in the uncontrollable painful condition. This activation is controlled for 
activation unrelated to subjective perception (constant regressor) and activation 
correlating with pain ratings. Statistical inference was based on a region of interest (ROI) 
analysis with a voxel-based threshold of Z = 1.6 and a cluster-based threshold of p = 0.05, 
corrected for multiple comparisons across the ROI. The activation is overlaid on the non-
linear MNI-152 template. Images are displayed in radiological convention, i.e., right side of 
the brain is on the left. 
 
Brain regions driving additional sensitization in the uncontrollable condition 
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To identify brain regions that drive the augmented pain perception in the 
uncontrollable condition, activation correlating with the moment-to-moment 
changes in pain perception was identified. ROI analysis demonstrated significant 
correlations in the PAG and pACC (Figure 18) but not in the amygdala. Further, 
activity in none of the ROIs (pACC, PAG, or amygdala) correlated with measures of 
locus of control or state or trait anxiety (p-values > 0.14). 
 
Discussion 
Here we show that uncontrollability-induced increases in pain ratings are reflected 
by increased activation of brain structures that are commonly implicated in pain 
processing. More importantly, augmented pain perception induced by 
uncontrollability was driven by increased activity in pACC and PAG, in line with our 
hypothesis. This finding extends the existing literature that had thus far not 
investigated brain regions responsible for uncontrollability-induced pain 
augmentation. Contrary to our hypothesis, the amygdala was not important for 
translating uncontrollability into pain facilitation: it did not show significant 
activation in the uncontrollable condition, and neither was its signal related to pain 
increase. Hence our results indicate important roles for the PAG and pACC in 
driving pain augmentation by uncontrollability but do not provide evidence for a 
role of the amygdala.  
Dissociation of pain perception in controllable and uncontrollable conditions 
During painful trials in the controllable condition, subjects showed temporal 
summation indicated by down-regulation of the temperature. Temporal 
summation in similar paradigms has been shown before (Becker et al., 2011; Hölzl 
et al., 2005; Kleinböhl et al., 1999) and has been related to NMDA receptor-
mediated wind-up of spinal cord neurons (Eide, 2000; Kleinböhl et al., 2006), not 
necessarily involving supraspinal mechanisms. This notion is supported by our 
finding that temporal summation in the controllable condition was not associated 
with increased activation in any pain-processing area, although nociceptive 
stimulation in this condition resulted in typical pain-related activation. This finding 
also indicates that subjects successfully kept their sensation constant. Further, we 
observed a positive correlation between self-adjusted temperature change and 
the subscale “powerful others” of the IPC locus of control scale indicating that the 
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degree of external control belief influences the extent of temporal summation. 
This is in accordance with theories of learned helplessness, as subjects who tend to 
belief that powerful others control their lives have increased pain sensations even 
in controllable situations. In line with previous psychophysical work using similar 
paradigms (cf. Becker et al., 2011; Hölzl et al., 2005), pain perception in the 
uncontrollable trials was dissociated from the controllable trials. Importantly, in 
the uncontrollable condition, the same nociceptive inputs were re-applied, 
thereby accounting for peripheral and spinal sensitization. Now, these 
temperature profiles were consistently rated by the subjects as increasingly 
painful over the course of the individual trials, clearly demonstrating the pain-
enhancing effects of uncontrollability (Borckardt et al., 2011; Müller, 2011). 
Pain-processing areas reflect uncontrollability-induced pain augmentation 
Areas that reflected the increased subjective ratings in the uncontrollable pain 
condition mainly receive nociceptive input via spinothalamic (Dum, Levinthal, & 
Strick, 2009) and spinopallidal (Braz, Nassar, Wood, & Basbaum, 2005) tracts and 
are typically found to be activated in pain imaging studies (Apkarian et al., 2005). 
These areas comprised bilateral anterior insula, rostral and mid ACC, 
supplementary motor cortex, bilateral thalamus, and lentiform nucleus. This is 
congruent with previous studies on uncontrollable pain stimuli (Mohr et al., 2005; 
Salomons et al., 2004) and indicates that the loss of control not only led to a 
reinterpretation of the painful stimulation (Wiech et al., 2006), but also to 
amplified processing of the nociceptive input. Nociceptive neurons that encode 
stimulus intensity have been reported in the insula (Ostrowsky et al., 2002), ACC 
(Sikes & Vogt, 1992), thalamus (Kenshalo, Giesler, Leonard, & Willis, 1980) and 
lentiform nucleus (Chudler & Dong, 1995), and imaging studies using increasing 
stimulus intensity to increase pain perception have observed that the signal in 
insula, ACC, supplementary motor cortex, basal ganglia, and thalamus scales 
linearly with the perceived intensity (Coghill et al., 1999; Loggia et al., 2012; 
Seminowicz & Davis, 2007). Taken together, this suggests that activation of these 
regions reflects increased perceived pain intensity in the present study as well as 
other studies on pain uncontrollability, rather than being regions driving the 
increases in pain perception.  
Brain areas driving uncontrollability-induced pain augmentation 
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We identified the PAG as being an important region behind the additional 
sensitization in the uncontrollable condition, possibly driven by the pACC. Due to 
the original design of the present study that allowed capturing moment-to-
moment changes of pain perception, we were able to add to previous work that 
had observed increased activation of these regions during uncontrollable 
compared to controllable painful stimulation (Mohr et al., 2005; Salomons et al., 
2004; Wiech et al., 2006). 
Albeit originally identified to inhibit pain, it is now clear that the descending pain 
modulatory system can equally facilitate spinal transmission of nociceptive 
information (Porreca et al., 2002). The brainstem, and in particular the PAG and 
the rostroventral medulla (RVM), are key relay structures of the descending pain 
modulatory system. The PAG integrates input from the spinal cord, hypothalamus, 
amygdala, pACC, insula, and orbitofrontal cortex (Basbaum & Fields, 1984; 
Hadjipavlou, Dunckley, Behrens, & Tracey, 2006), and can exert pro- or anti-
nociception depending on the respective circumstances and cognitive-emotional 
state (Bingel et al., 2006; Fairhurst, Wiech, Dunckley, & Tracey, 2007; Heinricher, 
Martenson, & Neubert, 2004; Monhemius, Green, Roberts, & Azami, 2001; Valet 
et al., 2004). An elegant body of work in animals has provided evidence that 
different sub-regions of the PAG are associated with different coping styles in 
response to painful stimuli (reviewed in Lumb, 2004). The ventrolateral PAG 
promotes passive coping when stimuli are inescapable (Keay, Clement, Depaulis, & 
Bandler, 2001). Uncontrollability and inescapability are distinct but closely related 
concepts and it could therefore be hypothesized that it is the ventrolateral portion 
of the PAG that is instrumental in uncontrollability-induced pain augmentation, 
although the spatial resolution of human fMRI does not allow making this 
distinction.  
The pACC projects to the PAG-RVM-spinal cord descending system (Müller-Preuss 
& Jurgens, 1976) and might via this route contribute to pain facilitation in the 
context of uncontrollability. The pACC has been suggested to play a major role in 
pain modulation by integrating contextual information and sensory processes 
(Bingel et al., 2006; Rainville, 2002). Interestingly, cognitive-emotional pain 
modulation by the pACC, demonstrated in the context of placebo analgesia (Bingel 
et al., 2006; Eippert et al., 2009) and distraction (Valet et al., 2004), has thus far 
only revealed pain inhibition. However, it is known from a study investigating 
sensitization induced by cutaneous application of capsaicin that activation in the 
pACC can also reflect pain facilitation (Lorenz et al., 2002). To our knowledge, the 
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present study is the first to present data implicating the pACC in pain facilitation by 
cognitive-emotional mechanisms. 
Uncontrollability has been associated with a reappraisal of the meaning of and 
increased attention to the painful stimulus in addition to being related to 
increased anxiety (Arntz & Schmidt, 1989; Bowers, 1968). We did not find evidence 
for a contribution of the amygdala and measures of anxiety to be related to 
uncontrollability-induced pain augmentation. Thus, uncertainty or anxiety might 
not play key roles in the paradigm employed here, possibly because subjects were 
familiarized with the experiment in an extra session. The relatively low scores in 
state anxiety support this notion. This finding is exciting because it suggests that 
the effects of uncontrollability on pain extend beyond effects of uncertainty or 
anxiety.   
In summary, our results indicate that loss of control leads to activation of a pro-
nociceptive circuitry, involving PAG and pACC. The pACC might translate the 
uncontrollability into pain facilitation, executed by descending pathways from the 
PAG to the spinal cord, amplifying transmission of incoming nociceptive signals. 
This amplification would result in enhanced activation of spinothalamocortical and 
spinopallidal pathways, resulting in increased activation of pain processing 
structures as well as increased pain perception, as observed in the present study. 
Clinical implications 
Chronic pain is in many instances uncontrollable. Evidence shows that 
experiencing uncontrollable pain can lead to hyper-vigilance to pain (Aldrich, 
Eccleston, & Crombez, 2000), learned helplessness, and depression, resulting in a 
self-amplifying vicious circle (Arntz & Schmidt, 1989). Further, losing control over 
pain potentially increases fear of pain and interferes with task performance 
(Crombez et al., 2008). In contrast, perceived control has been demonstrated to 
decrease pain and discomfort in acute pain (Thrash et al., 1982) and is associated 
with better functioning in chronic pain patients (Tan, Jensen, Robinson-Whelen, 
Thornby, & Monga, 2002). Understanding the endogenous pain facilitatory 
mechanisms underlying uncontrollability-induced pain augmentation might inform 
clinical approaches of pain management and therapy. For example, the results of 
the present study suggest that addressing anxiety is not sufficient to abolish 
uncontrollability-induced pain augmentation and point at the usefulness of 
promoting coping styles and strategies aimed at inc
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control, for example by active coping and reinterpretation of pain sensations 
(Haythornthwaite et al., 1998) or acceptance-based therapies (McCracken, 2004). 
 
 
Limitations 
Contrary to our hypothesis, we did not identify the amygdala as driving the 
uncontrollability-induced pain augmentation. However, the amygdala is a small 
brain structure located near air-filled cavities, which can cause reduced BOLD 
sensitivity due to intravoxel dephasing and susceptibility artefacts, compromising 
the signal-to noise-ratio (LaBar, Gitelman, Mesulam, & Parrish, 2001). In addition, 
the amygdala signal is often found to be transient (Bordi & LeDoux, 1992) and 
therefore, the sensitization occurring over relatively long periods might have 
precluded finding significant activation within the amygdala. For these two 
reasons, we cannot fully exclude that the amygdala might contribute to 
uncontrollability-induced pain augmentation. The aim of this study to differentiate 
between brain areas driving uncontrollability-induced pain augmentation and 
those reflecting increased pain was successfully achieved. Functional connectivity 
analysis might reveal further insights into the interplay between brain regions 
driving uncontrollability-induced pain augmentation. Due to the characteristics of 
the stimuli applied (tonic stimulation) functional connectivity analyses were not an 
option for this study but should be considered for future investigations.  
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4. General Discussion 
The present studies investigated the effects of nocebo-conditioning and 
uncontrollability, two psychological factors capable of facilitating the pain 
sensation. The results show that after changing the behavioral context in either 
case, physically identical stimulus intensities were perceived as more painful than 
before the manipulation. The pain modulatory effects were assessed on different 
response channels, resulting in notably increased subjective ratings of the pain 
sensation, altered implicit-behavioral responses, as well as activity in brain regions 
associated with pain processing. In detail, contingency awareness was not a 
necessary condition for nocebo conditioning, but successfully conditioned subjects 
were more sensitive in response to heat-pain than non-successfully conditioned 
subjects. Subjective pain enhancement in an uncontrollable task was reflected in 
increased brain activity in pain processing areas, modulated by pACC and PAG but 
not amygdala. The studies have important clinical implications as they contribute 
to a better understanding of pain facilitatory mechanisms and can potentially 
improve treatment options.  
 
4.1 Classical Conditioning of the Nocebo Effect 
Two different experiments demonstrated that a nocebo effect in heat-pain 
perception could be induced by means of classical conditioning without giving 
additional verbal suggestions or employing a cue that is prone to raise 
expectations from the outset (cf. Jensen et al., 2012). Previously, it was suggested 
that expectation, but not conditioning, is the crucial mechanism leading to 
nocebo-hyperalgesia, in contrast to placebo-hypoalgesia, in which both 
conditioning and expectation were assumed to play a significant role (Colloca et 
al., 2008; Petrovic, 2008). However, most studies did not test effects caused by 
conditioning separately (Benedetti et al., 2003; Benedetti et al., 2006; Bingel et al., 
2011; Colloca & Benedetti, 2006; Colloca et al., 2008; Voudouris et al., 1985; 
Voudouris et al., 1989). Thus, our results emphasize the important role of learning 
mechanisms in the development of the nocebo effect. Unquestionably, a very 
common route to develop nocebo-hyperalgesia is the generation of an explicit 
expectation of pain increase (Colloca et al., 2009; Schmid et al., 2013). However, 
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when a nocebo effect is induced by means of conditioning, it possesses 
characteristics of a conditioned response, which distinguishes it from an effect that 
is driven by an explicit expectation. It can be suggested that conditioned effects 
are more stable than effects caused by expectations, which has already been 
shown for placebo-hypoalgesia in patients with atopic dermatitis (Klinger et al., 
2007). Further, conditioned responses pertain characteristics like dose-
dependency (Pihl & Altman, 1971; Ross & Schnitzer, 1963), effects of the 
reinforcement schedule, extinction (Knowles, 1963), and prediction of the 
magnitude of the CR from the acquisition phase (Jensen et al., 2012). Knowledge 
on the qualities of the nocebo response is important because it leads to a better 
understanding of the underlying mechanisms; it becomes relevant when a nocebo 
effect is implemented in an experimental context as well as prevented or 
eliminated in the clinical context. 
As expected, not all subjects showed a nocebo effect, i.e., were successfully 
conditioned. In Study 1, 71.4 % and in Study 2, 50 % of the subjects were 
considered responders. We employed a responder criterion that depended on the 
difference between ratings of the stimulus presented after CS+ and CS– in the test 
phase of the experiment. This allocation was applied to the implicit-behavioral and 
autonomic measure (the latter only in Study 2), avoiding circular reasoning 
(Kriegeskorte et al., 2009). Beforehand, we investigated potential confounding 
variables that derived from a priori differences between subjects and difference 
during the learning phase. However, a classification of the subjects into learners 
and non-learners was not successful upon these analyses. For the placebo effect, 
usually a typical responder rate of 35 % to 66 % is assumed (Beecher, 1955; Rief, 
Hofmann, & Nestoriuc, 2008; Wickramasekera, 1980). No independent estimates 
for the nocebo effects have been published yet and there are no studies on 
separate responder rates after experimental manipulations by verbal suggestions 
or by conditioning. One study found that 19 % of the healthy subjects participating 
in a drug trial reported side effects despite being in the placebo group 
(Rosenzweig, Brohier, & Zipfel, 1993). Further, according to a focused review 
(Barsky et al., 2002), approximately 25 % of patients receiving placebos report 
adverse side effects. These findings indicate that the responder rates found in the 
present nocebo studies were presumably on average (Study 2) or above average 
(Study 1).  
A number of studies tried to establish personality traits that identify subjects that 
are prone to respond to placebo manipulations (e.g., hypnotizability, 
Wickramasekera, 1980; dispositional optimism, Morton et al., 2009; reward-
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related personality traits, Schweinhardt et al., 2009). But only few studies 
investigated correlations of personality traits with the nocebo effect. The results of 
Study 2 suggest that motivational style (assessing reward-related personality 
traits) and suggestibility were not related to the nocebo effect, further 
emphasizing that the nocebo effect is not just a reversed placebo effect. There is 
some evidence that neuroticism (Davis, Ralevski, Kennedy, & Neitzert, 1995), 
anxiety (Andrykowski & Redd, 1987; Uhlenhuth et al., 1998), pessimism (Geers, 
Helfer, Kosbab, Weiland, & Landry, 2005), hypochondriacal fear (Davis et al., 
1995), and somatization (Papakostas et al., 2004; Uhlenhuth et al., 1998) are 
positively related to the tendency to experience adverse side effects. A recent 
study in the context of nocebo-hyperalgesia showed that pain catastrophizing – 
and here especially the helplessness subscale – correlated with the nocebo effect 
(Vogtle et al., 2013). Another study showed that after a short (comprising five 
trials for each condition), but not a long conditioning procedure (comprising 20 
trials for each condition), nocebo responses were positively correlated with state 
and trait anxiety when using painful stimuli and negatively correlated when non-
painful stimuli were employed (Colloca et al., 2010). The authors concluded that by 
a long conditioning procedure, dispositional factors might become overruled. 
Further, increased anxiety accompanying a nocebo effect after an 
expectation/conditioning manipulation was reported by Bingel et al. (2011). These 
results support the notion that anxiety-triggered CCK activation might cause 
nocebo-hyperalgesia (Benedetti et al., 1997; Ploghaus et al., 2001). However, in 
another study that induced nocebo-hyperalgesia in a visceral pain model by 
expectancy manipulation, no correlation of the nocebo effect with state anxiety 
was reported (Schmid et al., 2013). One explanation by the authors was that with 
an expectation manipulation, a “cognitive pain modulation” might have been 
triggered compared to a conditioning manipulation that might rather trigger 
“emotional pain modulation” so that no changes in negative emotions could be 
detected. However, in a recent study that induced nocebo-hyperalgesia by an 
observational learning paradigm no correlation with pain-related fear (as assessed 
with PASS) was found as well (Vogtle et al., 2013). Accordingly, in the present 
Study 1 none of the implemented anxiety measures (STAI, PASS, FPQ) was related 
to the nocebo effect, which might be due to the relatively large number of trials 
(15 trials for each condition) comparable to the long conditioning procedure 
employed by Colloca et al. (2010). In Study 2, unexpectedly, a negative correlation 
of the hyperalgesic nocebo response with trait anxiety appeared. In concluding, 
the conflicting results of the present and previous studies suggest that the role of 
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anxiety in the context of the nocebo effect remains to be elucidated and needs 
further investigation. 
Our results rather suggest that pain sensitivity might play a role in the 
responsiveness for nocebo conditioning: In Study 1, in which the employed 
stimulus temperatures of the US depended on the pain threshold, successfully 
conditioned subjects had significantly higher pain thresholds than not successfully 
conditioned subjects. In Study 2, the stimulus temperatures were determined by a 
subjective rating procedure and during conditioning, successfully conditioned 
subjects reported significantly higher subjective ratings of the painful stimulus (US) 
compared to subjects that were not successfully conditioned, although stimulus 
intensities were comparable. These observations both point in the same direction 
and indicate that subjects that (subjectively or objectively) perceive more 
nociceptive input are more likely to develop a nocebo response. Further, Study 2 
showed that autonomic responses were different between non-learners and 
learners, the latter having increased heart rate and decreased heart rate variability 
parameters. Evidence shows that within the first three seconds of painful 
stimulation, the heart rate is determined by the stimulus intensity but after 
approximately six seconds it is rather related to the subjective evaluation of the 
stimulus (Möltner et al., 1990). Our results on the autonomic measures therefore 
might reflect the increased pain ratings of the learners. Accordingly, reduced 
increases in heart rate and sympathetic responses (0.15 Hz peak in spectral 
analysis of HRV) along with decreased pain ratings were observed in two studies 
on placebo analgesia induced by expectation manipulation and sham drug 
treatment (Pollo et al., 2003). Taken together, the results indicate that placebo-
hypoalgesia is accompanied by reduced heart rate and sympathetic activity, 
whereas nocebo-hyperalgesia seems to be accompanied by increased heart rate 
and decreased parasympathetic activity.  
With the subjective (difference between VAS2 and VAS1) and behavioral measure 
(difference between end and initial temperature of the self-regulation procedure), 
the short time development of the conditioned nocebo response was investigated 
for the first time. We interpreted the decreasing/decreased sensitivity in the 
absence of the nocebo cue as decomposition of the the conditioned response over 
time (“decay”). This decay was observed in Study 1: Both the subjective as well as 
the behavioral measure indicated increased adaption following the subjective 
nocebo response. The short time development of the nocebo response is 
potentially clinically relevant, as it might have direct behavioral consequences 
(e.g., by leading to relieving postures). However, in Study 2 these outcomes were 
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not replicated, which might be due to the modifications in Study 2 that generally 
led to a weaker conditioning effect compared to Study 1.  
The procedures employed in both nocebo studies were very similar. Both the CS 
and the US were temperature stimuli, i.e., processed within one system. Further, 
in contrast to implementing an association between a painful temperature and an 
artificial or irrelevant CS (i.e., visual cues, like a cross and a circle), having one 
temperature signaling another, higher temperature, harnesses naturally occurring 
relations (Domjan, 2005). Although the CS was not directly fear-relevant, we 
assume that preparedness (Seligman, 1972) facilitated the coupling of two 
temperature stimuli. However, in Study 2 we made some modifications in order to 
gain more information on specific determinants of the conditioned nocebo effect. 
One aim of Study 2 was to replicate the results of Study 1 in the subjectively 
painful range. We therefore employed a different strategy to determine the 
stimulus temperatures. Instead of using the individual pain threshold and units of 
JNDs as a basis from which the non-painful (pain threshold – 2.2 °C) and painful 
(pain threshold + 1.5 °C) stimuli were determined, we adapted a procedure that 
was based on the subjective evaluation of different intensities (Price et al., 1999). 
Different stimulus temperatures were presented to the subject and with a robust 
linear regression we predicted stimulus intensities that matched an individual 
rating of 50 and 70. Thereby we could increase the subjectively perceived level of 
stimulus intensity compared to Study 1. However, in the learning phase, the 
moderately painful stimulus, which was supposed to correspond to a rating of 50, 
was evaluated as non-painful. But then again, in the test phase, when cued by CS–, 
the successfully conditioned subjects rated this stimulus as indicated (M = 52), 
while the non-successfully conditioned subjects rated it as just painful on average 
(M = 40.5). When cued with CS+, the successfully conditioned subjects perceived 
the stimulus as clearly painful but the subjects who were not successfully 
conditioned rated it as non-painful. In the test phase of Study 1, the temperature 
was evaluated as non-painful after either cue. Interestingly, in the test phase of 
both studies, the successfully conditioned subjects rated the applied stimuli as 
significantly more painful than the non-successfully conditioned subjects on 
average. This indicates that, in a given context, the more intense stimuli are 
perceived, the more likely a nocebo effect develops. Considering the function of 
pain to protect the body from harm, this mechanism seems reasonable, as the 
motivation to end the painful condition or escape from it is increased by the 
nocebo effect. 
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In order to increase differentiation, we used a temperature pulse (quick increase 
of the temperature from baseline directly followed by a quick decrease back to 
baseline before presentation of the US temperature) instead of static temperature 
stimuli as CS, since the results of Study 1 showed that CS differentiation was 
beneficial for the nocebo effect. As a consequence, a trace conditioning paradigm 
was implemented as compared to Study 1, in which the conditioning paradigm was 
a borderline case of delay and trace conditioning. Further, to strengthen the 
nocebo effect, we prolonged the test phase by two trials and introduced three 
booster trials in the test phase of Study 2, in which we presented the painful 
stimulus cued by CS+. However, this modification might have corrupted the 
conditioning effect due to changes in adaptation level (Helson, 1947) and explain 
that less subjects were successfully conditioned.  
In summary, the presented studies show that, other than suggested (Benedetti et 
al., 2003; Colloca et al., 2008; Petrovic, 2008), classical conditioning is a feasible 
method for inducing a nocebo effect in the context of pain. Some of the 
modifications in Study 2 presumably led to an attenuation of the conditioning 
effect. The nocebo response was assessed on different measures, indicating that it 
is a real psychobiological phenomenon, not just a result of decreased pain being 
reported. 
 
4.2 The Role of Awareness in Nocebo-Conditioning 
The two present nocebo studies show that a conditioned nocebo effect can 
emerge without contingency awareness. In both studies, two thirds of the subjects 
were unaware of the contingency between the nocebo cue and the following 
painful stimulation. Expectancies are a common epiphenomenon of conditioning 
(Stewart-Williams & Podd, 2004), but subjects who remain contingency unaware, 
by definition, cannot develop an explicit expectation in regards to the nocebo cue. 
Thus, this result emphasizes the finding that a nocebo effect in pain perception 
does not depend on explicit expectation and can be induced by conditioning 
exclusively. This outcome has far reaching consequences for the clinical context, as 
it suggests that patients, unbeknownst, might learn associations between various 
cues and subsequent pain increase without even being able to recognize what 
exactly has caused the worsening. However, this prevents a patient from 
developing pain control strategies and can thereby contribute to the chronification 
or maintenance of a pain condition.  
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Previously, a study by Benedetti et al. (2003) showed that a negative verbal 
suggestion reduces markedly previous pharmacological placebo conditioning with 
an analgesic drug (keterolac). On the contrary, verbal suggestions of cortisol 
increase and growth hormone decrease did not lead to the according changes in 
hormone levels, and the same verbal suggestions after conditioning with 
sumatriptan (causing increase in growth hormone and decrease in cortisol) did not 
alter the conditioned effects (i.e., increase in growth hormone and decrease in 
cortisol; Benedetti et al., 2003). Based on these observations, it was suggested that 
for conscious physiological processes (like pain or motor performance), not 
conditioning but expectation (possibly formed by conditioning) is the crucial 
mechanism leading to a placebo or nocebo effect. Unconscious physiological 
processes, like hormone secretion, were sought to be mediated by conditioning 
only, as evidence showed that conditioning, but not verbal suggestions, affected 
the plasma concentration of growth hormone or cortisol (Benedetti et al., 2003). 
Likewise, it was shown that respiratory depression, an adverse side effect in 
analgesic therapy with opioids, occurs after conditioning with the partial opioid 
agonist buprenorphin (Benedetti et al., 1998; Benedetti et al., 1999). This effect 
was unnoticed by the subjects and did not depend on the hypoalgesic placebo 
effect so that the authors concluded that it was caused by conditioning and not by 
expectation. The fact that, in the present studies, contingency unaware subjects 
developed a nocebo effect strongly indicates that conditioned nocebo effects are 
not limited to unconscious physiological processes, as hypothesized in the past. 
Our results even go one step further than a recent study by Jensen et al. (2012), in 
which was shown that a nocebo effect can be activated by subliminally presented 
CS after an explicit conditioning procedure (using supraliminally presented CS) had 
taken place (although contingency awareness was not assessed here). Whereas 
this study suggests that explicit expectations are not necessary to activate nocebo-
hyperalgesia, the present results amend this by showing that explicit expectations 
are not necessary in the induction of the nocebo effect, either. Only one other 
study directly tried to induce placebo-hypoalgesia by implicit conditioning (Martin-
Pichora et al., 2011). In the implicit condition, an inert “anesthetic” and a control 
cream were applied on healthy subjects’ forearms and a tactile cue (upward or 
downward strokes to apply the cream) was used as CS and coupled to a lowered 
temperature during conditioning. In the test trial, the subjects did not know which 
cream was applied and only the direction of the strokes served as a cue. The 
results show that pain ratings were not reduced after administration of the 
placebo cue, indicating that the implicit conditioning procedure was not 
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successful. However, only one subject reported being aware of the different 
directions in which the cream was applied. Thus, the placebo effect might have 
been prevented by the lack in CS differentiation. Apart from a number of 
procedural concerns related to this study, the application of a cream seems 
disadvantageous in this specific context as this might already induce explicit 
expectations and cause placebo effects that are not separable from effects caused 
by the implicit conditioning. 
Implicit conditioning, beyond the placebo and nocebo context, is discussed 
controversially (Clark et al., 2002; Dawson & Biferno, 1973; Lovibond, 2002; Manns 
et al., 2002). Whereas some authors reject the possibility of conditioning without 
contingency awareness (e.g., Dawson & Schell, 1985; Dawson, 1970; Dawson & 
Biferno, 1973), others assert that it can only occur under specific conditions (e.g., 
autonomic conditioning, Knight, Nguyen, & Bandettini, 2003; Manns et al., 2001; 
Perruchet, 1985; Schultz & Helmstetter, 2010; with fear-relevant CS and aversive 
US, Esteves, Parra, Dimberg, & Öhman, 1994; Öhman, 1986; Soares & Öhman, 
1993; evaluative conditioning, Stevenson, Prescott, & Boakes, 1995; Stevenson, 
Boakes, & Prescott, 1998). Imaging studies support a dual process model of 
conditioning, assuming a double dissociation of contingency awareness and 
conditional fear responses. Whereas the former is sought to depend on 
involvement of hippocampal structures, the latter presumably rely largely on 
processing in the amygdala (Bechara et al., 1995; Knight, Waters, & Bandettini, 
2009; Tabbert et al., 2011). Further, implicit operant learning of pain sensitivity has 
been demonstrated in healthy subjects as well as fibromyalgia patients using 
similar response measures as in the present studies (Becker et al., 2012; Hölzl et 
al., 2005).  
A limiting factor in both nocebo studies was the weak test of contingency 
awareness. The subjects were interviewed after the experiment and answered 
questions regarding the sequence of the temperature stimuli (i.e., CS and US) with 
the aid of a flowchart depicting the temperature course of a trial. This approach 
has several pitfalls, for example by the time of the interview, subjects could 
already have forgotten about the contingencies (Lovibond, 2002). A superior 
alternative would have been a concurrent rating of US expectancy; however, this 
most certainly would have increased awareness. 
To sum up, in both studies, contingency awareness was no necessary condition for 
the development of a nocebo effect. This indicates that conditioning without 
expectancy is sufficient to induce a nocebo effect, even in the (partly) conscious 
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physiological process of pain (Benedetti et al., 2003). This result has important 
implications for the clinical context (please refer to section 4.5). 
 
4.3 Increased Sensitization Induced by Uncontrollability 
As a second pain facilitatory psychological factor, the effect of uncontrollability on 
perceived pain was investigated. Study 3 shows that when changing an 
experimental task from being controllable to uncontrollable, the same nociceptive 
input, previously self-adjusted to feel constant, is evaluated as getting increasingly 
painful. During the controllable task, i.e., when controlling the stimulus 
temperature and keeping it constant, subjects sensitized during painful trials 
(regulated the temperature down) and habituated during non-painful trials 
(regulated the temperature up). When, during the uncontrollable task, the same 
nociceptive input that was self-adjusted to feel constant was replayed, subjects 
rated it as getting more and more painful. This additional pain enhancement was 
reflected in increased activity in pain processing brain areas, like bilateral insula, 
rostral and mid ACC, supplementary motor cortex (BA8), bilateral thalamus, and 
lentiform nucleus. Further, brain areas known to play a role in pain modulation, 
namely PAG and pACC, appeared to drive this additional sensitization.  
Previous evidence shows that having a sense of control leads to decreased pain 
sensitivity (Borckardt et al., 2011; Bowers, 1968; Litt, 1988; Weisenberg et al., 
1985) and, on the other side, having no control increases the pain sensitivity 
(Crombez et al., 2008; Müller, 2012; Staub et al., 1971; Wiech et al., 2006). 
Different theories try to explain the pain increase induced by uncontrollability. 
Anxiety (Bowers, 1968) is often observed in this context (Crombez et al., 2008), but 
rather constitutes an epiphenomenon than an explanation for the pain increase 
(Arntz & Schmidt, 1989). In the present experiment, however, state and trait 
anxiety were not related to the extent of pain increase caused by uncontrollability, 
possibly because the subjects were familiarized with the experimental procedure 
before the actual testing. Further, the amygdala is well known for its involvement 
in fear-related processes (Neugebauer et al., 2004; Phelps & LeDoux, 2005) and we 
did not observe increased activation here (although this might be due to 
methodological difficulties in imaging this brain region). A widely accepted 
explanation for controllability-related changes in pain sensation refers to a 
reappraisal of the painful stimulation. According to Arntz & Schmidt (1989), 
(perceived) control alters the meaning of painful stimulation by reducing its 
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perceived threat. The same nociceptive input that was self-adjusted to feel 
constant during the controllable task presumably was reinterpreted to feel painful 
after losing instrumental control because the subject could no longer oversee the 
extend of the pain and potential harm (minimax hypothesis; Miller, 1979). Along 
these lines, in the present study, the sensitization during controllable painful 
stimulation positively correlated with an external locus of control belief (“powerful 
others”), indicating that locus of control beliefs can enhance the pain perception 
even when instrumental control is exerted. Appositely, evidence shows increased 
activity in ventrolateral PFC, a brain area known to be involved in reappraisal 
processes, in controllable compared to uncontrollable conditions (Wiech et al., 
2006), (Kalisch, Wiech, Critchley, & Dolan, 2006; Ochsner & Gross, 2005). Similarly, 
animal studies suggest a role for ventral medial PFC and it is hypothesized that this 
brain region inhibits activity in the doral raphe nucleus in rats when stress is 
controllable (Amat et al., 2005). However, in the present study, no significant 
prefrontal activity was detected. Correspondingly, we also did not observe 
behavioral immunization (Seligman & Maier, 1967), i.e., an effect in which 
experience of control leads to resilience in later situations of no control (Amat, 
Paul, Zarza, Watkins, & Maier, 2006) and which seems to rely on ventral medial 
PFC as well. 
The results show that the pain increase that was induced by uncontrollability was 
driven by increased activity in perigenual ACC and PAG. These brain structures are 
well known for their role in pain modulation (Bingel et al., 2006; Fairhurst, Wiech, 
Dunckley, & Tracey, 2007; Heinricher, Martenson, & Neubert, 2004; Monhemius, 
Green, Roberts, & Azami, 2001; Valet et al., 2004), for example from studies that 
investigated placebo analgesia (Bingel et al., 2006; Eippert et al., 2009) and 
distraction (Valet et al., 2004). Accordingly, evidence shows that functional 
connectivity between those brain regions is high (Kong, Tu, Zyloney, & Su, 2010). 
Although some evidence demonstrates that pain facilitation is mediated by this 
circuitry of brain areas, as well (Porreca et al., 2002), previous studies almost 
exclusively investigated pain modulation by means of inhibition. Thus, our study 
contributes to a better understanding of the interrelation between pain inhibition 
and pain facilitation. 
According to the typology of control (please refer to 1.2) previous studies mainly 
used procedures that classify as self-administration and/or instrumental control. 
Most studies employed manipulations, in which the subject could self-administer 
or end a painful stimulation in the controllable condition and was administered a 
yoked painful stimulation by the experimenter in the uncontrollable condition. For 
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instance, in the controllable condition, the subjects pulled a rope to apply the 
painful stimulation after a verbal command (and sometimes were able to end the 
stimulation by pulling again; Mohr et al., 2008) and in the uncontrollable condition 
the experimenter applied the stimulation after a variable time interval following a 
verbal signal (Helmchen et al., 2006; Mohr et al., 2005) A similar procedure was 
used by Müller (2011; Müller, 2012); here the subjects could self-administer 
electric shocks within a time window of 10 seconds, contrasted to administration 
of the shocks by the experimenter according to a random schedule. In a study by 
Wiech et al. (2006), the subjects were told that they could stop painful stimuli 
when the pain becomes unbearable in the self-controllable condition, whereas the 
painful stimulation was stopped by experimenter or a computer in the externally 
controlled condition. Another possibility to manipulate perceptions of control was 
posed by subjects’ performance in reaction time tasks. Subjects were led to belief 
that they could reduce the duration of a painful stimulation if they responded 
correctly and quickly enough in the controllable condition, but their response had 
no consequence in a non-controllable condition (controllability or lacking control 
was prompted before each trial; Borckardt et al., 2011; Salomons et al., 2004). In 
the present procedure, contrasting to previous studies, subjects had direct control 
over the intensity of the nociceptive input (i.e., the applied temperature) during 
the controllable trial. This approach seems to be a much more powerful 
manipulation of perceived control than a decision at which point in time a painful 
stimulus is self-administered within a narrow time frame. It further allowed 
tracking the changes in pain sensation over time in both the controllable and 
uncontrollable conditions. This made it possible to identify not only brain regions 
that correlated with the pain increase but also those regions that drove the pain 
augmentation. 
Some limitations deserve mention concerning the study on uncontrollability. Due 
to the yoked-control design, controllable trials always preceded uncontrollable 
trials in the two functional scans that were separated by the anatomical scan. 
Therefore, an effect of order cannot completely be ruled out, although we verified 
that pain ratings across trials did not change (cf. Figure SIV), suggesting that the 
increase in pain perception in the uncontrollable trials was not due to sensitization 
over time. Another aspect concerns the characteristics of the experimental tasks. 
The controllable and the uncontrollable tasks were not completely equivalent. In 
the former, the subjects had to actively keep a temperature constant whereas in 
the latter, they had to passively rate the temperature throughout the trial. An 
‘active task’, however (e.g., in which subjects have to control something else but 
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pain), would prevent the assessment of perceived pain intensity and therefore 
preclude ensuring that stimulus uncontrollability in the task indeed increased pain 
perception. In our view, it is important to not only show more brain activation in 
pain processing regions to infer successful pain augmentation by uncontrollability, 
but to also show the effect on a behavioral level. Therefore, it was necessary to 
assess the perceived pain intensity. Furthermore, the uncontrollable task allowed 
to observe continuous changes in perception (while equating motor output 
between the two tasks), thereby differentiating between brain regions that 
reflected and those that drove increased pain perception. Also, it could be argued 
that an ‘active’ component is an inherent constituent of exerted controllability. In 
line with this view, controllable conditions in previous studies on pain 
controllability typically contained an active component that was absent in the 
uncontrollable condition (e.g., termination of painful stimulus by the subject vs. by 
another person). Further, having control over something else while simultaneously 
receiving pain stimuli would introduce other important confounds, most 
importantly distraction, which is known to decrease pain perception (Valet et al., 
2004; Villemure et al., 2003). A second limitation regarding the experimental tasks 
is related to the different response channels represented by the behavioral task 
and the subjective rating. As already discussed (please refer to sections 1.3 and 
4.4), pain is a multidimensional phenomenon and different measures do not have 
to correspond. It is thus possible that the pain increase that was observed in the 
subjective ratings during the uncontrollable trials was (partly) due to the method 
of assessment and level of processing (i.e., implicit-behavioral versus subjective-
verbal). In conclusion, we think that the advantages of our experimental paradigm 
outweigh potential disadvantages; however future studies should incorporate 
different methods of assessment within both the controllable and the 
uncontrollable task in order to exclude potential confounding sources. 
In summary, in the present study on uncontrollability, increases in pain report 
after induction of a nocebo effect led to increased activity in pain processing 
regions as well as involvement of the descending pain modulatory circuit, including 
rACC and PAG, which were shown to drive the changes in pain sensation induced 
by uncontrollability. 
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4.4 Multidimensional Assessment of the Pain Response  
Pain is a multidimensional experience that can be assessed on different response 
channels. Most studies on pain ask the subjects to give a verbal rating of the pain 
sensation and/or pain unpleasantness (VAS, NRS). But verbal ratings are prone to 
response bias and demand characteristics (Kienle & Kiene, 1997; Hrobjartsson & 
Gotzsche, 2001; Chapman et al., 1985). Further, they only represent one facet of 
the pain experience and here only aspects that are explicitly represented. The 
subjective evaluation of a painful event certainly is of major interest in research as 
well as in clinical routine, but it is not sufficient to represent the complex 
experience of pain as a whole. In order to get a more comprehensive picture of the 
pain experience, in the presented studies, we additionally assessed a dynamic 
behavioral measure indicating the change in pain sensation over a short period of 
time, thereby observing adaptation effects on an implicit, behavioral level. 
Concretely, the subjects had the task to keep the temperature sensation constant 
by operating a computer mouse. The self-adjusted change in temperature thus is 
interpreted as temporal summation (self-adjusted decrease of the temperature) or 
adaption (self-adjusted increase in temperature). It can be assumed that this 
behavioral measure is an implicit indicator of the pain sensitivity as the subjects 
are not aware that their temperature adjustments constitute a type of response 
measure for their subjective perception (Becker, 2009; Hölzl et al., 2005). In 
addition to the implicit-behavioral response, autonomic measures (heart rate and 
HRV) as correlates of the pain perception were assessed. Autonomic variables can 
shed light on the affective-motivational component of the pain experience and 
also have the advantage of being independent from verbal report (Möltner et al., 
1990). The importance of autonomic measures in the context of pain gets obvious 
when referring to pain conditions that demonstrably show an involvement of the 
autonomic system. For instance, pain in the complex regional pain syndrome 
(CRPS) is at least in part thought of as being maintained sympathetically (Stanton-
Hicks et al., 1995), which led to the development of interventions targeting the 
sympathetic nervous system (e.g., ganglion stellate blocks; van Eijs et al., 2012). In 
the present nocebo study (Study 2), learners and non-learners differed in their 
heart rate and HRV, suggesting that the autonomic response might be an indicator 
of successful learning. Finally, neural correlates of the pain experience were 
investigated. According to Chapman et al. (1985), correlates of pain can help 
confirming the validity of pain experiments, increase statistical power by providing 
additional information for hypothesis testing, and help to assess related aspects of 
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the pain experience, like anxiety. However, in addition to that, by understanding 
the neural activity that occurs during experience of a painful event, aberrant 
processes in pain conditions can be better explained and therapies might be 
tailored accordingly (for example in phantom pain, please refer to section 1). 
Further, the investigation of neural correlates of pain, in the future, might reveal 
an opportunity for diagnosis and treatment of subjects who are not 
communicative, for example due to advanced dementia or in states with altered 
consciousness (e.g., minimally conscious; Schnakers, Faymonville, & Laureys, 
2009). Dissociations between different measures (Becker et al., 2011; Hölzl et al., 
2005) can arise because pain is not a uniform construct. Thus, the investigation of 
the pain experience on different response channels is worthwhile because 
disadvantages of single assessment methods can be compensated and more 
information gathered.  
The behavioral and subjective measures were adopted differentially in the nocebo 
studies and the study on uncontrollability. In the former, the behavioral measure 
indicated the decay of the conditioned response as assessed with subjective 
ratings within one trial and it was complemented by the subjective indicator of 
decay. Thereby, it was possible to show that the nocebo effect neither solely 
depended on demand characteristics nor was a consequence of response bias 
because a conditioned effect was observable in both the subjective ratings and the 
behavioral measure (at least in Study 1). Further, this approach allowed to 
evaluate the development of the nocebo response over time and characterize its 
decomposition. In the study on uncontrollability, the behavioral task formed the 
controllable condition, taking advantage of the fact that by keeping the 
temperature constant, the subjects exerted control over the nociceptive input. The 
self-adjusted temperature course was replayed for the uncontrollable condition, in 
which the subjects continuously rated their sensation, without having control over 
the nociceptive input any longer. Increases in pain sensation did not depend on 
peripheral sensitization because this was already accounted for during the 
behavioral task. Thus subjectively perceived pain increases could be attributed to 
the loss of control. Although, a limitation of this approach is that the experimental 
conditions (controllable and uncontrollable) were not completely similar, 
controllability was manipulated indirectly, intrinsic to the experimental tasks. This 
prevented the subjects from becoming aware of the purpose of the experiment 
and hence avoided effects of demand characteristics
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When it comes to imaging studies, the investigation of pain facilitation (Gebhart, 
2004; Lorenz et al., 2005; Ploghaus et al., 2001; Suzuki, Rygh, & Dickenson, 2004; 
Yang & Symonds, 2012) compared to pain inhibition (e.g., distraction, Bantick et 
al., 2002; Tracey et al., 2002; hypnotic suggestions, Rainville, Carrier, Hofbauer, 
Bushnell, & Duncan, 1999; placebo effects, Petrovic et al., 2002; Wager et al., 
2004) is largely neglected as well. Interestingly, neural correlates of the nocebo 
effect show an involvement of similar brain areas as observed in the present study 
on controllability. After an expectation/conditioning nocebo manipulation that led 
to increased intensity ratings, (Kong et al., 2008) found increased activation of the 
medial pain system responsible for affective-emotional and cognitive aspects of 
the pain perception (including ACC, insula, superior temporal gyrus, operculum, 
and PFC). According to Bingel et al. (2011), the analgesic effect of the opioid 
remifentanyl on heat pain was completely abolished after an 
expectation/conditioning manipulation. Further, increased pain and anxiety were 
mirrored in increased activation of pain processing brain regions (medial cingulate 
cortex, thalamus, SI, insula). Similarly, nocebo suggestions in a visceral pain model 
led to increased subjective pain as well as insular activation (Schmid et al., 2013). 
Some evidence suggests a specific involvement of hippocampal structures in the 
nocebo effect (Bingel et al., 2011; Kong et al., 2008), a brain area also known to 
play a role in learning (cf. Olsson & Phelps, 2007; Ploghaus et al., 2001). According 
to a review by Tracey (2010), pain modulation due to placebo and nocebo 
manipulations is mediated by the descending pain modulatory system, consisting 
of rostral ACC, hypothalamus, amygdala, PAG, and rostral ventral medulla. 
Although evidence is still limited in the placebo context, the involvement of these 
brain regions was demonstrated in several studies (Eippert et al., 2009; Petrovic et 
al., 2002; Wager et al., 2004; Wager, Scott, & Zubieta, 2007). Further it was shown 
that this descending pain modulatory system is activated in pain facilitation as well 
(Gebhart, 2004; Suzuki et al., 2004).  
 
4.5 Clinical Relevance 
The results of the present studies help us to understand the mechanisms 
underlying pain facilitation, which are largely under-investigated. The same 
processes might be clinically relevant. Patients “always expect the worst” as they 
oftentimes have not made many good experiences and feel out of control. It is 
known by now that the choice of the wording in doctor-patient interactions has an 
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impact on the patient’s wellbeing (Benedetti, 2002; Lang et al., 2005). The present 
nocebo studies, however, emphasize the possible influence of learning processes 
in this context. For instance, due to latent inhibition, it is assumed that yearlong 
experience of ineffective therapies, which is a typical experience of many chronic 
pain patients, has a negative impact on later interventions (Bingel et al., 2011; 
Klinger et al., 2007; Voudouris et al., 1985). This effect might further be enhanced 
by the patient’s growing sense of uncontrollability in the face of his pain condition, 
which leads to feelings of helplessness, fueling a vicious circle of increasing pain 
(Arntz & Schmidt, 1989), as evidence shows that susceptibility for a nocebo 
response is positively related to the extent of helplessness a person feels (Vogtle 
et al., 2013). The finding that a nocebo effect can develop even without the 
patient being aware of the contingency between cue and pain increase has 
especially important clinical implications. Implicit learning makes it even harder for 
the patient to interrupt the vicious circle of classically conditioned pain increase, 
operantly reinforced pain behavior (Flor, Birbaumer, & Turk, 1990) and growing 
sense of uncontrollability, potentially resulting in a gradual increase in pain 
sensitivity because the patient is not aware of the cause of the pain increase and 
thus cannot counteract it. 
The insights of both studies could be used to improve often unsuccessful pain 
therapy. The choice of an intervention or medication should be carefully 
considered to prevent the patient from experiencing a therapy as ineffective and 
his pain as uncontrollable. Accordingly, when prescribing analgesic medication, the 
dosage should not be chosen too reluctant as reservation might be harmful. A 
serious potential consequence of nocebo effects (in terms of adverse side effects) 
is non-compliance and/or discontinuation of pharmaceutical interventions (Rief et 
al., 2008), which contributes to therapy failure in the end. Patients with negative 
prior experience as well as negative control beliefs thus need special interventions 
to attenuate possible adverse effects (Rief et al., 2008), for example by employing 
strategies to enhance cognitive re-appraisal processes. Awareness needs to be 
raised in patients as well as physicians and other healthcare professions. Also, the 
patient’s coping style and locus of control beliefs need to be addressed 
appropriately and patients should be provided with as much control as possible. It 
might be worthwhile here to incorporate response channels that are oftentimes 
neglected, for example, biofeedback training of autonomic or neurophysiological 
responses (Miltner, Larbig, & Braun, 1988).  
Knowledge on neural processes of pain facilitation will potentially help to develop 
treatment options. For example, fast repetitive transcranial magnetic stimulation 
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(rTMS) of the dorsolateral PFC (Borckardt et al., 2011) has shown to suppress 
hypoalgesic effects of controllability. Similarly, low-frequency rTMS on dorsolateral 
PFC blocked expectation-induced placebo-hypoalgesia (Krummenacher, Candia, 
Folkers, Schedlowski, & Schonbachler, 2010). As rTMS can have inhibiting or 
enhancing effects depending on the applied frequency, it might provide an option 
for pain management when the relationship between neural and psychological 
factors that cause or maintain a pain condition is better understood. 
 
4.6 Conclusions and Outlook 
Evidence shows that pain facilitation compared to pain inhibition is considerably 
understudied, despite direct relevance for the clinical context. Investigating the 
effects of nocebo-conditioning and the induction of uncontrollability, complex 
response patterns were observable in subjective and implicit behavioral response 
channels as well as autonomic and neural correlates. The results show that 
psychological factors exert powerful influence on the pain experience although 
many aspects need further clarification. In addition to that, a multidimensional 
assessment of the pain perception and its correlates proves beneficial, providing 
several starting points for the future assessment of pain facilitation: 
- The present results show that nocebo-conditioning and uncontrollability 
can increase the pain sensitivity in healthy volunteers. It is yet plausible 
that the nocebo effect or classical conditioning in general as well as 
feelings of uncontrollability may play a role in the development and 
maintenance of chronic pain. The present paradigms could be employed 
on patients to further explore this hypothesis. 
 
- A number of alterations in the experimental procedure presumably 
attenuated the conditioned nocebo effect in Study 2. Future studies 
should optimize the conditioning procedure by systematically investigating 
determinants of successful conditioning (e.g., conditioning design).   
 
- The present nocebo studies were the first to consider the temporal course 
(i.e., decay) of the nocebo responses. Similarly, consequences of 
uncontrollability have never been studied before under the aspect of 
development over time. Further, implicit-behavioral indices of pain 
processing are rarely implemented. These approaches should be pursued 
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and patients with pain conditions should be investigated because temporal 
characteristics and implicit-behavioral indices of pain processing are 
potentially relevant in a clinical context. 
 
- Nocebo-conditioning and uncontrollability paradigms might complement 
each other in order to further explore a potential common ground of 
neural correlates of pain facilitatory effects. 
 
- Anxiety is hypothesized to play a role both in the nocebo effect and in 
uncontrollability, however, experimental support is inconsistent. Future 
studies should clarify this issue, for example by implementing repeated 
interrogation on the current level of anxiety. 
 
- Uncontrollability and, as a consequence, learned helplessness are relevant 
not only in chronic pain, but also in depression and posttraumatic stress 
disorder (Başoğlu & Mineka, 1992). Accordingly, the present paradigm 
could be modified and applied to these patient populations in order to 
further elucidate the mechanisms at work. 
Hence, the plans for future applications and development of the present results 
are threefold: (1) systematic investigation of experimental aspects (e.g., 
conditioning design) that determine the success of the nocebo-conditioning 
procedure (e.g., stability, effect size); (2) the present paradigms should be applied 
to patient groups (e.g., chronic pain, depression, etc.) in order to elucidate 
underlying mechanisms of the respective pathological condition; (3) the present 
paradigms can be utilized to investigate common neural correlates of pain 
facilitatory effects. 
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Summary 
Nocebo effects and uncontrollability are important psychological factors in pain 
facilitation and play a major role the context of acute and chronic pain. However, 
the precise mechanisms in both phenomena that lead to pain increase remain 
understudied. The general aim of the three studies contained in this thesis was to 
shed light on mechanisms of conditioning-induced nocebo effects and neuronal 
processes during uncontrollability-induced pain increase. For this purpose, 
experimental designs were employed that assessed the pain perception and its 
epiphenomena on multiple response channels (subjective verbal report, 
behavioral response, autonomic response, neuronal activity).  
In the first study, a conditioning procedure was developed without additional 
verbal suggestions or employment of cues that are prone to induce expectations 
of pain relief or worsening. The results indicated that conditioning can induce a 
subjective nocebo effect, even when subjects are contingency unaware (implicit 
conditioning). The decay of this conditioned response over time was observable in 
subjective as well as behavioral measures. Neither state nor trait anxiety or 
measures of anxiety specifically related to pain showed a correlation with this 
nocebo effect in the subjectively non-painful range.  
The second study adapted the conditioning procedure in order to induce nocebo-
hyperalgesia. Further, the impact on autonomic measures was explored and 
relations between the nocebo response and personality traits were investigated. 
Nocebo-hyperalgesia as indicated by the subjective measure was successfully 
induced in part of the sample, independent from contingency awareness. 
Successfully conditioned subjects compared to non-successfully conditioned 
subjects showed to be habitually less anxious, received higher stimulus intensities 
despite comparable subjective sensation, and demonstrated increased heart rate 
and decreased HRV parameters. Motivational style and suggestibility were not 
related to the nocebo response. 
Study three investigated neural correlates of uncontrollability-induced pain 
increase. During controllable pain trials, subjects showed temporal summation, 
but adapted during controllable warm trials, as indicated by the behavioral 
measure. During the uncontrollable pain condition, subjective intensity ratings 
increased over the course of the individual trials, despite subjects received the 
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identical nociceptive input that they had regulated to feel constant in the 
controllable condition. The additional pain increase in the pain trials, induced by 
uncontrollability, was mirrored in increased activation of pain processing brain 
regions, such as thalamus, insula, SII, and ACC. Importantly, activity in perigenual 
ACC and PAG drove the uncontrollability-induced pain increase. These results 
suggest that the loss of control leads to activation of a pro-nociceptive circuitry 
also assumed to play a role in placebo and nocebo effects that involve the pain 
modulatory regions PAG and pACC. 
In summary, these studies demonstrated a) the powerful impact of psychological 
factors, such as learning and uncontrollability, on pain perception, and b) proved 
the benefit of a multidimensional assessment of pain perception and its correlates. 
These results improve our understanding of pain facilitatory processes and have 
important implications for therapeutical interventions in pain conditions. They can 
further promote research in other fields, for example concerning the role of 
classical conditioning and neural processes in chronic pain. 
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Appendix 
 
Supplementary Figure I: 
 
Figure SI: Displayed are quantile-quantile (QQ) plots of the subjective ratings (VAS1) of 
painful trials during the learning phases of Study 1 (A) and Study 2 (B). In order to classify 
subjects into different groups we put 2 (Study 1) or 3 (Study 3) straight lines through the 
distribution of single trials and allocated the subjects (n) into one group (of two or 
accordingly three groups) according to their mode within trials, as indicated by the dashed 
lines.  
 
 
 
 
 
 
 
 
 
 
Appendix 
 
116 
Supplementary Figure II: 
 
Figure SII: Subjective rating (VAS2 after the behavioral task) throughout Study 1. Depicted 
are subjective ratings (mean and standard errors of mean) of trials cued with CS+ (black) 
and CS– (grey) during the learning phase (A) and the test phase (B) of the whole sample (N 
= 21) and during the test phase of the learner subgroup (C; N = 13), and non-learner 
subgroup (D; N = 8). The dashed line depicts the pain threshold (VAS = 40). Linear mixed 
model analyses revealed that both CS were rated differently during the learning phase 
(main effect ‘CS’: F(1, 52.01) = 476.7, p < .001) and remained stable over time (main effect 
‘time’: F(14, 181.9) = 0.39, p = .976; interaction effect ‘CS’ x ‘time’: F(14, 273.1) = 1.1, p = 
.357). During the test phase, the rating of trials cued with both CS was not different (main 
effect ‘CS’: F(1, 44) = 0.87, p = .356), but increased over time (main effect ‘time’: F(4, 78.6) 
= 3.93, p = .006), which was the same for both CS (interaction effect ‘CS’ x ‘time’: F(4, 81.4) 
= 0.93, p = .452). When restricting the analyses to the learner subgroup, subjects did not 
differentiate between trials cued with either CS (main effect ‘CS’: F(1, 33.2) = 1.97, p = 
.169) and the ratings did no change over time (main effect ‘time’: F(4, 56.8) = 1.87, p = 
.128; interaction effect ‘CS’ x ‘time’: F(4, 58.3) = 2.24, p = .076). 
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Supplementary Figure III: 
 
Figure SIII: Subjective ratings (VAS2 after the behavioral task) throughout Study 2. 
Depicted are subjective ratings (means and standard errors of mean) of trials cued with 
CS+ (black) and CS– (grey) during the learning phase (A) and test phase (B) of the whole 
sample (N = 22) and during the test phase of the learner subgroup (C; N = 11) and non-
learner subgroup (D; N = 11). The dashed line depicts the pain threshold (VAS = 40). 
Analyses showed that during the learning phase, the subjects perceived moderately painful 
trials as more painful than mildly painful trials (main effect ‘CS’: F(1, 523.3) = 1784.4, p < 
.001), which did not change over time (main effect ‘time’: F(14, 567.8) = 0.72, p = .753; 
interaction effect ‘CS’ x ‘time’: F(14, 523.3) = 0.8, p = .674). During the test phase, the 
subjects did not rate trials differently when cued with either CS (main effect ‘CS’: F(1, 
189.5) = 0.91, p = .341) and there was no change over time (main effect ‘time’: F(6, 201.8) 
= 0.37, p = .0.9; interaction effect ‘CS’ x ‘time’: F(6, 189.4) = 1.02, p = .417). The learner 
subgroup rated trials cued with CS+ as more painful than with CS– (main effect ‘CS’: F(1, 
94.8) = 4.8, p = .031), which did not change over time (main effect ‘time’: F(6, 100.5) = 
0.16, p = .986; interaction effect ‘CS’ x ‘time’: F(6, 94.8) = 0.9, p = .502). 
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Supplementary Figure IV: 
 
 
Figure SIV: Intensity ratings of the uncontrollable trials, averaged across participants with 
standard error of means. The arrows pointing at the x-axis indicate the time points of the 
controllable trials (6 trials each). The ratings remained stable across the uncontrollable 
trials, which is supported by the results of the mixed model analysis (interaction effect Trial 
x Intensity: F(5, 514) = 0.7, p = 0.626). The dashed line depicts the pain threshold (VAS = 
40). 
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Supplementary Table I: Brain responses to painful vs. warm stimulation, 
irrespective of the task (controllable and uncontrollable painful > controllable 
and uncontrollable warm). 
    MNI peak 
coordinates in 
mm 
brain region cluster size (# 
of voxels) 
Z score 
peak 
later-
ality 
x y z 
cluster spanning the 
following   regions: 
32627 6.73 bl 56 0 0 
       insula  6.26 bl 34 2 8 
SII  6.24 bl 46 -2 2 
ACC  4.71 bl 4 10 44 
thalamus  6.21 bl 18 -16 12 
cerebellum  6.06 bl -30 -60 -34 
superior temporal   gyrus  6.73 bl 56 0 0 
One big cluster spanning several typical pain processing areas was significantly more 
activated by painful compared to non-painful stimulation (significant on a whole brain-
level, voxel-based threshold Z = 2.3 and cluster-based threshold p < 0.05). Local maxima 
within the cluster are given for individual anatomical areas. SII, secondary somatosensory 
cortex; ACC, anterior cingulate cortex; bl, bilateral. 
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Supplementary Table II: Brain responses to uncontrollable painful stimulation 
compared to controllable painful stimulation (uncontrollable painful > 
uncontrollable painful). 
    MNI peak 
coordinates 
in mm 
brain region cluster size (# 
of voxels) 
Z score 
peak 
later-
ality 
x y z 
cluster spanning the 
following    regions: 
2163 4.99 bl 18 -16 10 
       
PAG  3.99 r 16 -26 -16 
thalamus  4.99 bl 18 -16 10 
       
premotor cortex 1059 5.27 r 22 4 56 
precuneus cortex 407 4.17 bl -16 -66 26 
       
cluster spanning the 
following regions: 
11345 6.25 bl -10 -100 -6 
       
visual cortex  6.25 bl -10 -100 -6 
cerebellum  5.95 bl -12 -56 -50 
Listed are brain areas in which activation was significant on a whole brain-level, voxel-
based threshold Z = 2.3 and cluster-based threshold p < 0.05. Please note that local 
maxima are given as peaks if a significant cluster encompassed more than one region. PAG, 
periaqueductal gray; bl, bilateral; r, right. 
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Supplementary Table III: Brain activation correlated with sensitization in the 
controllable condition. 
    MNI peak 
coordinates 
in mm 
brain region cluster size (# 
of voxels) 
Z score 
peak 
later-
ality 
x y z 
cluster spanning the 
following regions: 
1463 3.98 bl -6 -30 38 
       posterior cingulate 
cortex 
 3.98 bl -6 -30 38 
precuneus cortex  3.93 bl -2 -44 54 
       
cluster spanning the 
following regions: 
682 3.35 bl -14 -38 -8 
       parahippocampal gyrus  3.35 l -14 -38 -8 
cuneal cortex  3.17 r 8 -84 42 
visual cortex  3.15 l -10 -66 12 
       cluster spanning the 
following regions: 
580 3.56 r 30 -16 58 
       premotor cortex  3.56 r 30 -16 58 
SI  3.36 r 48 -20 50 
MI  3.26 r 46 -10 34 
       
cluster spanning the 
following regions: 
319 3.34 r 18 -38 -4 
       parahippocampal gyrus  3.34 r 18 -38 -4 
lingual gyrus  3.09 r 16 -38 -12 
       
visual cortex 2156 3.86 bl 18 -100 -2 
Listed are brain areas in which activation was significant on a whole brain-level, voxel-
based threshold Z = 2.3 and cluster-based threshold p < 0.05. Please note that local 
maxima are given as peaks if a significant cluster encompassed more than one region. SI, 
primary somatosensory cortex; MI, primary motor cortex; bl, bilateral; r, right; l, left. 
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Supplementary Table IV: Brain activation reflecting the additional sensitization in 
the uncontrollable condition. 
    MNI peak 
coordinates 
in mm 
brain region cluster size (# 
of voxels) 
Z score 
peak 
later-
ality 
x y z 
cluster spanning the 
following regions: 
1275 3.67 bl 6 24 52 
       anterior cingulate cortex  3.29 bl 4 34 18 
premotor cortex  3.67 r 6 24 52 
       
cluster spanning the 
following regions: 
1084 3.75 r 44 18 -4 
       insula  3.52 r 44 8 -8 
frontal operculum   3.75 r 44 18 -4 
temporal pole  3.7 r 50 18 -8 
       
cluster spanning the 
following regions: 
689 3.92 l -44 14 -4 
    -44 14 -4 insula  3.93 l 44 14 -4 
SII  2.9 l -48 -8 6 
temporal pole  2.89 l -54 10 -6 
       
cluster spanning the 
following regions: 
 3.31 bl 16 -8 8 
       thalamus  3.31 bl 16 -8 8 
pallidum  3.11 r 12 -8 -6 
       
cluster spanning the 
following regions: 
1440 5.04 bl 14 -84 -16 
       occipital fusiform gyrus  5.04 r 14 -84 -16 
visual cortex  3.63 bl 6 -92 -6 
Listed are brain areas in which activation was significant on a whole brain-level, voxel-
based threshold Z = 2.3 and cluster-based threshold p < 0.05. Please note that local 
maxima are given as peaks if a significant cluster encompassed more than one region. SII, 
secondary somatosensory cortex; bl, bilateral; r, right; l, left. 
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